This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_RECTUM_EXALLC for full statistics.
Malignant neoplasm of rectum
C3_RECTUM
rectum cancer: A primary or metastatic malignant neoplasm that affects the rectum. Representative examples include carcinoma, lymphoma, and sarcoma.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
3597 |
4. Check minimum number of eventsNone |
3597 |
5. Include endpointsNone |
3597 |
6. Filter based on genotype QC (FinnGen only) |
3597 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of rectum
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)
- Colorectal cancer
- Colorectal cancer, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of digestive organs
- Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3597 | 1366 | 2231 |
| Unadjusted period prevalence (%) | 0.79 | 0.47 | 0.98 |
| Median age at first event (years) | 67.61 | 65.86 | 68.68 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3320
- Matched controls
- 33198
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
21.8
323.0
1653
1443
130
Kela drug reimbursment
Malignant tumour
20.2
323.0
1758
1748
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
615.3
323.0
1599
50
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
401.8
323.0
590
18
JGB07
NOMESCO Finland
Laparoscopic partial proctectomy with total excision of mesorectum
469.6
323.0
340
8
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
11.1
323.0
864
1020
WF001
NOMESCO Finland
Preoperative radiotherapy
355.6
323.0
788
29
JG1BG
NOMESCO Finland
MRI of rectum
248.2
323.0
541
26
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
16.0
323.0
550
407
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
4503599627370496.0
323.0
2887
*
JG1CG
NOMESCO Finland
Extensive MRI of rectum
286.5
323.0
447
18
A03FA01
ATC
metoclopramide; systemic, rectal
6.9
323.0
1657
4199
JGB00
NOMESCO Finland
Partial proctectomy and colorectal or coloanal anastomosis
141.9
323.0
389
31
WX302
NOMESCO Finland
Thoracal epidural anesthesy
17.7
323.0
1025
816
JFG10
NOMESCO Finland
Closure of loop colostomy without resection
142.3
323.0
625
54
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
2413.6
323.0
2836
75
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
342.0
323.0
543
19
JFF23
NOMESCO Finland
Transversostomy
111.4
323.0
696
79
A04AA02
ATC
granisetron; systemic, transdermal
10.5
323.0
787
954
JGB06
NOMESCO Finland
Partial proctectomy with total excision of mesorectum
404.1
323.0
479
14
UJF32
NOMESCO Finland
Coloscopy
9.6
323.0
2247
5940
D37.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Rectum
79.4
323.0
442
64
L01BC06
ATC
capecitabine; oral
55.1
323.0
1426
447
Z93.3
ICD-10 Finland
Colostomy status
94.2
323.0
441
54
TJF80
NOMESCO Finland
Ostomy education
69.5
323.0
441
73
C20
ICD-10 Finland
Malignant neoplasm of rectum
2148.3
323.0
800
5
JN4BD
NOMESCO Finland
Extensive body CT
7.2
323.0
1191
2395
D75
ICPC
Malignant neoplasm colon/rectum
63.9
309.1
360
63
JGB30
NOMESCO Finland
Abdominoperineal excision of rectum
546.3
306.0
300
6
B01AB05
ATC
enoxaparin; parenteral
3.9
288.4
1752
7332
H02AB02
ATC
dexamethasone; systemic
6.0
279.4
889
1915
UJG02
NOMESCO Finland
Proctoscopy
18.3
275.3
441
276
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
9.8
261.6
567
686
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
14.8
257.9
450
348
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
10.4
241.8
503
560
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
8.4
236.7
564
793
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
14.1
223.6
397
316
WX408
NOMESCO Finland
General anesthesy, balanced
3.5
223.6
1454
6042
JFG20
NOMESCO Finland
Closure of enterostomy with resection of exteriorised loop
120.3
218.3
235
21
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.4
218.2
1561
6943
JGB31
NOMESCO Finland
Laparoscopic and perineal excision of rectum
554.7
212.5
209
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
17.8
209.8
338
210
WZC30
NOMESCO Finland
Teaching
4.3
203.0
892
2612
JN4AD
NOMESCO Finland
Body CT examination
5.3
201.7
688
1547
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
67.0
199.6
231
37
C19
ICD-10 Finland
Malignant neoplasm of rectosigmoid junction
48.6
196.5
240
53
WX600
NOMESCO Finland
Single shot through catheter
29.0
196.4
270
101
XX3DW
NOMESCO Finland
Time consuming IT work
4.7
194.3
759
1969
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
10.3
193.9
402
437
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
12.4
187.5
353
316
JFF11
NOMESCO Finland
Laparoscopic loop enterostomy
331.0
185.2
186
6
ZX095
NOMESCO Finland
Combined chemoradiotherapy
41.2
174.3
220
57
JGB03
NOMESCO Finland
Partial proctectomy with partial excision of mesorectum
64.6
167.6
195
32
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
6.9
156.7
422
690
JFF10
NOMESCO Finland
Loop enterostomy
54.9
156.5
187
36
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
7.8
150.7
369
524
JGB04
NOMESCO Finland
Laparoscopic partial proctectomy with partial excision of mesorectum
187.9
138.7
144
8
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
10.8
136.8
274
274
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
7.2
132.6
340
514
SPAT1125
SPAT
Stoma care and guidance
12.0
130.7
248
222
TPH07
NOMESCO Finland
Cathetrisation of artery
3.5
126.5
673
2218
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
6.1
123.4
359
643
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
11.3
120.8
236
224
JFG40
NOMESCO Finland
Revision of enterostomy or colostomy without laparotomy
52.2
120.4
145
29
ZX070
NOMESCO Finland
Intensity modified radiotherapy
9.3
117.0
254
293
8480/3-C20.9
ICD-O-3
Mucinous adenocarcinoma of rectum, NOS
1167.7
116.4
113
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
4.8
114.6
418
970
JGB37
NOMESCO Finland
Laparoscopic wide excision of rectum
386.7
113.1
113
*
JN4CD
NOMESCO Finland
Very extensive body CT
5.4
112.6
362
730
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
5.1
109.4
374
808
WX402
NOMESCO Finland
General anaesthesia
3.0
105.9
735
2897
N02AA05
ATC
oxycodone; systemic
2.8
104.4
807
3404
8240/3-C20.9
ICD-O-3
Neuroendocrine tumor, NOS, of rectum, NOS
+∞
101.5
97
*
Z93
ICD-10 Finland
Artificial opening status
47.2
100.4
123
27
JGB36
NOMESCO Finland
Wide excision of rectum
986.5
98.5
96
*
SPAT1262
SPAT
Handing over of treatment supplies
2.5
91.5
894
4270
B01AB10
ATC
tinzaparin; parenteral
3.8
89.1
418
1216
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
7.9
87.9
210
282
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
15.3
87.2
147
100
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
9.8
87.1
182
195
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
4.1
87.1
367
970
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
9.5
86.6
184
203
ZX090
NOMESCO Finland
Other technic of radiotherapy
6.2
86.0
245
422
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
8.9
85.9
190
225
Z43.3
ICD-10 Finland
Attention to colostomy
60.6
85.3
100
17
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.0
84.4
552
2059
L01BC59
ATC
trifluridine, combinations; systemic
116.9
84.3
91
8
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.3
84.0
237
403
Z51.5
ICD-10 Finland
Palliative care
3.7
81.8
396
1179
D18
ICPC
Change in faeces/bowel movements
7.6
81.2
198
274
A04AA01
ATC
ondansetron; systemic, rectal
3.8
80.2
367
1041
ZXC96
NOMESCO Finland
Robot assisted procedure
5.8
79.7
239
439
1541A
ICD-9 Finland
Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectum[NEOPLASMA MALIG RECTI,INVASIIVINEN KARSINOOMA]
786.1
78.7
77
*
369
Kela drug reimbursment
Regorafenib
76.3
78.5
89
12
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
4.5
77.6
292
690
JG1DG
NOMESCO Finland
Very extensive MRI of rectum
765.2
76.6
75
*
1506
Kela drug reimbursment
The combination of trifluridine and tipiracil
80.3
76.4
86
11
JGB01
NOMESCO Finland
Laparoscopic partial proctectomy and colorectal or coloanal anastomosis
163.8
76.4
80
5
3018
Kela drug reimbursment
The combination of trifluridine and tipiracil
79.3
75.4
85
11
YL1CD
NOMESCO Finland
Very extensive CT examination of pelvis for dose design of radiotherapy
67.8
74.7
86
13
JF2AB
NOMESCO Finland
Colongraphy with X-ray
38.6
73.9
94
25
JGB10
NOMESCO Finland
Partial proctectomy and end colostomy
77.4
73.4
83
11
TQW40
NOMESCO Finland
Remowal of suture of skin
3.4
71.7
378
1199
D99
ICPC
Disease digestive system other
13.2
70.3
126
99
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.8
70.2
500
1954
JFF27
NOMESCO Finland
Laparoscopic sigmoidostomy
183.8
69.3
72
*
JN3AD
NOMESCO Finland
Abdominal CT examination
3.1
66.4
402
1408
WX306
NOMESCO Finland
Lumbar epidural anesthesy
4.4
65.9
252
603
ZX120
NOMESCO Finland
Intravenous
2.9
65.5
451
1718
176
Kela drug reimbursment
Regorafenib
63.9
64.6
75
12
C21.0
ICD-10 Finland
Malignant neoplasm: Anus, unspecified
81.8
64.2
72
9
Z43.2
ICD-10 Finland
Attention to ileostomy
81.8
64.2
72
9
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.4
63.7
336
1062
JG1CM
NOMESCO Finland
Extensive MRI of rectum (more than 1.5 T)
322.9
63.6
64
*
1XC07
NOMESCO Finland
NA
73.7
63.3
72
10
K91.4
ICD-10 Finland
Colostomy and enterostomy malfunction
46.3
62.9
77
17
QBE15
NOMESCO Finland
Excision of other superficial lesion of skin of trunk
18.3
62.6
98
55
JGB20
NOMESCO Finland
Partial rectosigmoidectomy and abdominoperineal pull-through anastomosis
+∞
61.6
59
*
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
8.5
59.9
135
165
JAH00
NOMESCO Finland
Laparotomy
5.0
55.5
188
396
Z98.0
ICD-10 Finland
Intestinal bypass and anastomosis status
17.5
54.7
87
51
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
54.4
825
4647
C21.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of rectum, anus and anal canal
280.6
54.3
55
*
JGA73
NOMESCO Finland
Transanal excision of lesion of rectum
27.6
53.1
73
27
N02BE01
ATC
paracetamol; systemic, rectal
2.0
52.0
2820
24346
R4110
NOMESCO Finland
Physiotherapy
1.9
51.5
972
5926
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
4.8
49.4
171
368
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
6.2
49.0
136
226
K45.8
ICD-10 Finland
Other specified abdominal hernia without obstruction or gangrene
13.5
48.9
86
65
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
15.0
48.7
82
56
WF049
NOMESCO Finland
Radiotherapy of metastasis
4.0
48.4
205
538
WF004
NOMESCO Finland
Palliative radiotherapy
5.2
46.9
152
305
JJB10
NOMESCO Finland
Atypcal resection of liver
23.5
46.7
67
29
C21.1
ICD-10 Finland
Malignant neoplasm: Anal canal
86.3
45.9
51
6
JN2CM
NOMESCO Finland
Lower part of abdomen extensive MRI examination with Tesla magnet
13.0
44.8
80
63
JFB00
NOMESCO Finland
Partial resection of small intestine
5.9
44.7
129
225
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
9.4
43.3
91
99
Z93.2
ICD-10 Finland
Ileostomy status
22.1
43.1
63
29
6435
FHL
Abdominoperineal resection and colostomy
151.9
42.9
45
*
L01XE21
ATC
[U] regorafenib; oral
56.3
42.5
50
9
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
18.2
42.3
66
37
K56.7
ICD-10 Finland
Ileus, unspecified
5.6
40.8
122
223
Z51.0
ICD-10 Finland
Radiotherapy session
6.8
40.6
105
159
JN2BD
NOMESCO Finland
Extensive CT exmaniation of lower part of abdomen
23.6
40.5
58
25
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
11.1
40.5
78
72
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
5.4
40.5
125
237
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
11.4
40.1
76
68
JG001
NOMESCO Finland
Preopertaive radiotherapy of rectum
+∞
39.6
38
*
JH1CG
NOMESCO Finland
Extensive MRI of perianal area
21.8
39.6
58
27
WW500
NOMESCO Finland
Blood transfusion
3.3
39.3
213
683
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
5.5
38.8
118
220
WF002
NOMESCO Finland
Radical radiotherapy
2.7
38.4
274
1052
A04AD12
ATC
aprepitant; systemic
5.5
38.4
117
219
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
4.7
38.2
134
293
JFF26
NOMESCO Finland
Sigmoidostomy
35.5
38.1
49
14
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.4
38.0
194
594
JFF24
NOMESCO Finland
Laparoscopic transversostomy
50.6
37.6
45
9
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.2
36.6
144
353
8070/3-C20.9
ICD-O-3
Squamous cell carcinoma, NOS, of rectum, NOS
+∞
36.5
35
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
3.5
35.6
177
531
XJG12
NOMESCO Finland
Transrectal endoscopic ultrasonography
38.0
35.6
45
12
8000/3-C20.9
ICD-O-3
Neoplasm, malignant of rectum, NOS
+∞
35.5
34
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.8
35.3
157
430
E0000UV
ATC
NA
1.6
35.2
1182
8390
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
6.0
35.0
99
169
A04AA55
ATC
palonosetron, combinations; systemic
4.3
34.0
129
306
N03AX16
ATC
pregabalin; oral
1.7
33.4
771
4903
JGB11
NOMESCO Finland
Laparoscopic partial proctectomy and end colostomy
330.1
32.9
33
*
UJF30
NOMESCO Finland
Ileoscopy through colon
2.2
32.7
346
1636
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
22.7
32.6
47
21
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
3.5
32.6
160
476
B01AB04
ATC
dalteparin; parenteral
2.8
32.2
220
823
A06AC01
ATC
ispaghula (psylla seeds); oral
1.7
31.7
818
5361
6434
FHL
Anterior resection
48.0
31.5
38
8
D37.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Colon
4.9
30.9
103
214
D16
ICPC
Rectal bleeding
4.6
30.1
107
238
R4190
NOMESCO Finland
Nutritional therapy
3.8
30.1
131
353
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
4.0
30.0
124
319
JJB50
NOMESCO Finland
Excision of segments V, VI, VII and VIII of liver
21.2
30.0
44
21
JAG41
NOMESCO Finland
Repair of stomal hernia, laparoscopic
156.3
29.7
31
*
D01.2
ICD-10 Finland
Carcinoma in situ: Rectum
107.6
29.7
32
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
5.1
29.6
96
194
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
4.5
29.5
107
243
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.9
29.4
446
2449
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
6.2
29.3
80
131
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
2.5
29.0
238
990
C209
ICD-10 Finland
NA
151.2
28.7
30
*
A79
ICPC
Malignancy NOS
5.0
28.2
92
187
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
3.4
27.9
140
424
V03AF03
ATC
calcium folinate; systemic
22.5
27.8
40
18
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
11.7
27.6
51
44
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
10.1
26.7
53
53
LEC00
NOMESCO Finland
Partial excision of vagina
73.2
25.8
29
*
JN2BG
NOMESCO Finland
MRI examination of lower part of abdoment with high intensity magnet
10.8
25.5
49
46
K92.1
ICD-10 Finland
Melaena
2.3
25.2
237
1056
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
6.5
25.2
66
103
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
4.8
24.5
83
177
JFB60
NOMESCO Finland
Resection of sigmoid colon with end colostomy
8.1
24.4
55
69
XX1AD
NOMESCO Finland
Other CT-examination
8.3
24.3
54
66
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
6.5
24.1
63
98
WX704
NOMESCO Finland
Intubation
2.2
24.1
252
1181
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
3.6
24.1
110
310
JJB30
NOMESCO Finland
Excision of two segments of liver
29.3
24.1
32
11
JG1BM
NOMESCO Finland
MRI of rectum (more than 1.5 T)
241.5
23.7
24
*
15411
ICD-8 Finland
Malignant neoplasm of rectum and rectosigmoid junction, Rectum
241.5
23.7
24
*
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
4.8
23.6
79
166
L01BC53
ATC
tegafur, combinations; systemic
19.6
23.4
35
18
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.5
23.3
193
805
1541X
ICD-9 Finland
Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectum[NEOPLASMA MALIG RECTI,EI HISTOLOGISTA VAHVISTUSTA]
+∞
22.9
22
*
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
3.6
22.6
106
305
JHA00
NOMESCO Finland
Anal or perianal incision
5.4
22.3
67
125
ZX080
NOMESCO Finland
Image guided radiotherapy
3.7
22.3
99
273
JJB71
NOMESCO Finland
Laparoscopic resection of liver
35.3
22.0
28
8
8210/3-C20.9
ICD-O-3
Adenocarcinoma in adenomatous polyp of rectum, NOS
+∞
21.9
21
*
C18.90
ICD-10 Finland
Malignant tumor in unspecified location in the colon without histology
9.7
21.8
44
46
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
3.9
21.2
89
234
8144/3-C20.9
ICD-O-3
Adenocarcinoma, intestinal type of rectum, NOS
+∞
20.8
20
*
JA3CT
NOMESCO Finland
Cathetrisation of abdominal cavity with CT guidance
37.4
20.8
26
7
Z71.8
ICD-10 Finland
Other specified counselling
1.6
20.7
620
4168
Z31.5
ICD-10 Finland
Genetic counselling
3.2
20.6
113
367
NET99
NOMESCO Finland
Other operation on pelvis
110.7
20.6
22
*
K59.09
ICD-10 Finland
Constipation, unspecified
2.2
20.5
225
1080
P01AB01
ATC
metronidazole; oral, rectal
1.5
20.2
1073
8193
JN2DM
NOMESCO Finland
Lower part of abdomen very extensive MRI examination with Tesla magnet
10.4
20.1
39
38
JAH01
NOMESCO Finland
Laparoscopy
2.7
20.1
139
525
UJF12
NOMESCO Finland
Enteroscopy through intestinal stoma
14.5
19.8
33
23
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.0
19.7
263
1367
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
13.2
19.7
34
26
XX4AT
NOMESCO Finland
Other canalization with ultrasound guidance
10.7
19.4
37
35
JWF00
NOMESCO Finland
Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery
12.7
19.3
34
27
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
8.8
19.3
41
47
JFK10
NOMESCO Finland
Freeing of adhesions in intestinal obstruction
9.6
19.3
39
41
K43.5
ICD-10 Finland
Parastomal hernia without obstruction or gangrene
31.4
19.2
25
8
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.2
19.1
200
937
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
3.7
19.0
84
232
TJG20
NOMESCO Finland
Transanal irrigation
12.8
18.9
33
26
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
2.9
18.8
114
396
JFF30
NOMESCO Finland
Other colostomy
20.9
18.6
27
13
1XC08
NOMESCO Finland
NA
190.9
18.5
19
*
D17
ICPC
Incontinence of bowel
6.3
18.5
49
79
JEA00
NOMESCO Finland
Appendectomy
2.2
18.1
181
830
JAG43
NOMESCO Finland
Repair of stomal hernia with mesh
52.8
17.9
21
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
5.7
17.8
51
91
JJB20
NOMESCO Finland
Excision of single segment of liver
22.9
17.7
25
11
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.3
17.7
66
157
JFG50
NOMESCO Finland
Laparotomy with revision of enterostomy or colostomy
36.9
17.6
22
6
JGA98
NOMESCO Finland
Other transluminal endoscopic local operation on rectum
36.9
17.6
22
6
D12.4
ICD-10 Finland
Benign neoplasm: Descending colon
3.4
17.6
85
253
R19.4
ICD-10 Finland
Change in bowel habit
3.2
17.4
94
304
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
4.0
17.4
69
174
ZX121
NOMESCO Finland
Central venous catheter
9.5
17.3
35
37
K61.1
ICD-10 Finland
Rectal abscess
12.0
17.3
31
26
D12.9
ICD-10 Finland
Benign neoplasm: Anus and anal canal
5.7
17.2
49
87
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.6
17.1
541
3666
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
4.8
17.1
57
121
S18
ICPC
Laceration/cut
1.4
16.9
1304
10575
UJF34
NOMESCO Finland
Left colonoscopy
6.5
16.7
43
67
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.2
16.7
170
790
JFA58
NOMESCO Finland
Endoscopic dilatation of colon
12.7
16.6
29
23
UJH02
NOMESCO Finland
Anoscopy
2.4
16.6
144
616
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
2.8
16.6
106
383
JN3GE
NOMESCO Finland
Intraoperative ultrasound examination of abdomen
16.4
16.5
26
16
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
16.5
570
3948
D28
ICPC
Limited function/disability (D)
8.6
16.4
35
41
D29
ICPC
Digestive symptom/complaint other
3.4
16.2
77
227
XJA00
NOMESCO Finland
Intraoperative abdominal ultrasonography
15.4
16.2
26
17
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
2.3
16.1
158
720
K45.0
ICD-10 Finland
Other specified abdominal hernia with obstruction, without gangrene
16.8
16.1
25
15
N82.3
ICD-10 Finland
Fistula of vagina to large intestine
21.0
16.0
23
11
R50.9
ICD-10 Finland
Fever, unspecified
1.6
15.9
420
2716
TPX15
NOMESCO Finland
Removal of vascular injection port
8.6
15.9
34
40
JAG96
NOMESCO Finland
Other reconstruction of abdominal wall
33.5
15.7
20
6
JWW96
NOMESCO Finland
Other reoperation in gastroenterological surgery
11.7
15.5
28
24
LEE10
NOMESCO Finland
Repair of vagina using graft or flap
160.6
15.5
16
*
C18.99
ICD-10 Finland
Malignant tumor in unspecified location in the colon other or unspecified histology
6.8
15.4
38
56
JJB40
NOMESCO Finland
Excision of segments II, III and IV of liver
38.2
15.4
19
5
JJB60
NOMESCO Finland
Other excsion of three or more segments of liver
38.2
15.4
19
5
JFB20
NOMESCO Finland
Ileocaecal resection
7.3
15.2
36
50
K56.0
ICD-10 Finland
Paralytic ileus
4.5
15.0
52
116
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.8
14.7
248
1402
J01MA12
ATC
levofloxacin; systemic
1.5
14.5
606
4359
C18.91
ICD-10 Finland
Malignant tumor of unspecified location in colon invasive carcinoma
15.4
14.4
23
15
A06AD11
ATC
lactulose; oral
1.5
14.2
507
3521
WX882
NOMESCO Finland
High dependency care
2.6
14.2
105
415
JGA75
NOMESCO Finland
Endoscopic microsurgical excision of lesion of rectum
19.2
14.2
21
11
JWA00
NOMESCO Finland
Repair of wound dehiscence in gastroenterological surgery
5.4
14.2
42
79
JAD10
NOMESCO Finland
Repair of incisional hernia
4.8
14.2
46
96
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
5.0
14.1
44
88
A06AH03
ATC
naloxegol; oral
4.1
13.9
53
130
T81.9
ICD-10 Finland
Unspecified complication of procedure
3.2
13.8
73
234
Y83.2
ICD-10 Finland
Surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
8.6
13.7
29
34
WX110
NOMESCO Finland
Local anesthesy
1.3
13.4
1835
16053
R03AC02
ATC
salbutamol; inhalant
0.7
13.3
958
11720
JGA05
NOMESCO Finland
Endoscopic polypectomy in rectum
5.4
13.3
39
73
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.2
13.2
140
660
LCD00
NOMESCO Finland
Hysterectomy
2.4
13.1
114
492
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
3.8
13.1
54
143
TJX90
NOMESCO Finland
Other minor procedure in gastroenterological surgery
16.8
13.0
20
12
WX725
NOMESCO Finland
Noninvasive ventilation
2.1
12.8
147
720
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.4
12.8
112
485
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
4.4
12.7
45
103
C18.9
ICD-10 Finland
Malignant neoplasm: Colon, unspecified
10.5
12.7
24
23
XJW99
NOMESCO Finland
Other investigative procedure on digestive system
9.0
12.7
26
29
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
3.6
12.7
57
162
KCC10
NOMESCO Finland
Cystoprostatectomy
6.0
12.7
34
57
K62.1
ICD-10 Finland
Rectal polyp
3.9
12.6
50
128
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.8
12.5
237
1395
JHA10
NOMESCO Finland
Biopsy of anal canal
20.1
12.4
18
9
A02BC02
ATC
pantoprazole; systemic
1.3
12.4
1951
17313
Y88
ICD-10 Finland
Sequelae with surgical and medical care as external cause
4.7
12.4
41
88
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
3.3
12.4
62
192
K63.1
ICD-10 Finland
Perforation of intestine (nontraumatic)
4.2
12.3
45
107
JFG30
NOMESCO Finland
Closure of colostomy with resection of exteriorised loop
14.4
12.2
20
14
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.3
12.1
1386
11757
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
4.2
12.1
45
109
R33
ICD-10 Finland
Retention of urine
1.6
11.9
307
1969
WB101
NOMESCO Finland
Simple cytostatic neoadjuvant therapy
13.4
11.9
20
15
JJ6LT
NOMESCO Finland
Coagulation of focal hepatic lesion under ultrasound guidance
13.4
11.9
20
15
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
3.3
11.7
58
179
JKA20
NOMESCO Finland
Cholecystectomy
2.3
11.6
107
478
GDB10
NOMESCO Finland
Wedge resection of lung
10.1
11.5
22
22
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.7
11.5
245
1494
M25.5
ICD-10 Finland
Pain in joint
0.7
11.4
385
5322
D77
ICPC
Malignant digestive neopl other/NOS
6.0
11.3
30
50
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
2.5
11.2
86
349
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
5.0
11.2
35
71
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
6.2
11.2
29
47
R01AD09
ATC
mometasone; nasal
0.7
11.0
712
8896
J01MA02
ATC
ciprofloxacin; systemic
1.3
11.0
1189
9965
K43.0
ICD-10 Finland
Incisional hernia with obstruction, without gangrene
4.1
10.9
41
101
178
Kela drug reimbursment
Combination product containing tegafur, gimeracil and oteracil
11.9
10.8
19
16
KBH20
NOMESCO Finland
Replantation of ureter
11.9
10.8
19
16
SPAT1153
SPAT
Removal of sutures
1.3
10.7
974
7960
WX002
NOMESCO Finland
Sedation and analgesia
1.4
10.7
570
4276
K60.4
ICD-10 Finland
Rectal fistula
12.9
10.6
18
14
K46.9
ICD-10 Finland
Unspecified abdominal hernia without obstruction or gangrene
5.1
10.6
32
63
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
6.0
10.6
28
47
JAG00
NOMESCO Finland
Repair of other hernia
11.2
10.5
19
17
H03AA01
ATC
levothyroxine sodium; systemic
0.7
10.5
316
4465
G47.3
ICD-10 Finland
Sleep apnoea
0.7
10.5
322
4531
JF2CG
NOMESCO Finland
Extensive MRI of colon
110.3
10.4
11
*
8010/3-C20.9
ICD-O-3
Carcinoma, NOS, of rectum, NOS
+∞
10.4
10
*
C18.72
ICD-10 Finland
Malignant tumor of sigmoid carcinoma of adenoma
5.6
10.4
29
52
G04CA02
ATC
tamsulosin; oral
1.3
10.3
918
7470
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.7
10.3
455
6030
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
2.5
10.3
80
327
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
0.7
10.3
462
6106
SPAT1131
SPAT
Colonoscopy
2.1
10.3
110
526
JGA85
NOMESCO Finland
Endoscopic mucosal or submucosal resection in rectum
10.6
10.3
19
18
Z85.0
ICD-10 Finland
Personal history of malignant neoplasm of digestive organs
8.8
10.3
21
24
M01AC06
ATC
meloxicam; systemic, rectal
0.7
10.1
650
8147
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
0.7
10.0
510
6611
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.3
10.0
884
7177
K43.3
ICD-10 Finland
Parastomal hernia with obstruction, without gangrene
40.2
10.0
12
*
R19.5
ICD-10 Finland
Other faecal abnormalities
3.3
9.9
48
147
R03DC03
ATC
montelukast; oral
0.6
9.9
162
2594
JGA96
NOMESCO Finland
Other proctotomy or local operation on rectum
16.7
9.9
15
9
A28
ICPC
Limited function/disability NOS
1.4
9.8
491
3641
WGA11
NOMESCO Finland
Planning of pain management
13.4
9.7
16
12
JFA86
NOMESCO Finland
Closure of fistula of colon
55.1
9.6
11
*
R02
ICPC
Shortness of breath/dyspnoea
0.6
9.5
146
2376
C18.79
ICD-10 Finland
Malignant tumor of the sigmoid or other unspecified histology
4.9
9.4
29
59
KBV00
NOMESCO Finland
Insertion of stent into ureter
4.9
9.4
29
59
8490/3-C20.9
ICD-O-3
Signet ring cell carcinoma of rectum, NOS
+∞
9.4
9
*
J01FA06
ATC
roxithromycin; oral
0.8
9.3
764
9289
R15
ICD-10 Finland
Faecal incontinence
2.3
9.2
79
341
M01AH05
ATC
etoricoxib; oral
0.8
9.2
1163
13443
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
3.6
9.2
39
108
K65.0
ICD-10 Finland
Acute peritonitis
3.2
9.2
46
145
JFH20
NOMESCO Finland
Proctocolectomy and ileostomy
13.7
9.2
15
11
N48.4
ICD-10 Finland
Impotence of organic origin
2.5
9.1
69
279
R11
ICD-10 Finland
Nausea and vomiting
1.7
9.1
207
1285
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.7
9.1
515
6586
M75.1
ICD-10 Finland
Rotator cuff syndrome
0.7
9.0
382
5101
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.4
9.0
384
2757
K43.2
ICD-10 Finland
Incisional hernia without obstruction or gangrene
7.0
9.0
21
30
JFB30
NOMESCO Finland
Right hemicolectomy
2.7
8.9
59
223
J01FA10
ATC
azithromycin; systemic
0.8
8.9
1007
11800
JFK00
NOMESCO Finland
Division of adhesive band in intestinal obstruction
6.8
8.8
21
31
UJF32
SPAT
NA
2.9
8.8
52
183
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
1.7
8.8
196
1210
R06.0
ICD-10 Finland
Dyspnoea
0.7
8.8
442
5752
TJX00
NOMESCO Finland
Punkture or biopsy in gastrointestinal endoscopy
9.5
8.8
17
18
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.3
8.7
74
320
N02AX02
ATC
tramadol; systemic, rectal
1.3
8.7
1235
10621
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.9
8.7
120
636
M17.1
ICD-10 Finland
Other primary gonarthrosis
0.7
8.7
364
4875
C21.2
ICD-10 Finland
Malignant neoplasm: Cloacogenic zone
50.1
8.7
10
*
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
0.8
8.7
556
6994
R05
ICPC
Cough
0.7
8.6
320
4369
K59.1
ICD-10 Finland
Functional diarrhoea
1.8
8.6
138
773
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
0.6
8.6
120
1992
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
4.0
8.5
32
80
R07.4
ICD-10 Finland
Chest pain, unspecified
0.7
8.5
506
6429
WX892
NOMESCO Finland
Monitored bed care
1.6
8.5
229
1486
L01EX05
ATC
regorafenib; oral
27.6
8.5
11
*
GDB20
NOMESCO Finland
Segmental resection of lung
20.1
8.5
12
6
JFW98
NOMESCO Finland
Other transluminal endoscopic operation on intestine
90.2
8.4
9
*
L03AA02
ATC
filgrastim; parenteral
2.2
8.4
84
391
K91.3
ICD-10 Finland
Postoperative intestinal obstruction
12.8
8.4
14
11
JHA20
NOMESCO Finland
Excision of lesion of anal canal or perianal tissue
3.5
8.3
37
107
R83
ICPC
Respiratory infection other
0.7
8.3
205
3015
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.4
8.3
430
3202
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.4
8.3
457
3437
ZZR10
NOMESCO Finland
Flap of skin and muscle
4.1
8.3
30
73
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
4.5
8.2
27
60
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.0
8.1
103
531
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
0.5
8.1
82
1486
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.6
8.1
222
1451
JFA83
NOMESCO Finland
Excision of lesion of colon
33.4
8.1
10
*
JFC20
NOMESCO Finland
Other enterocolostomy
22.1
8.0
11
5
JJA43
NOMESCO Finland
Destruction of lesion of liver
22.1
8.0
11
5
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
0.7
7.9
258
3600
J01.0
ICD-10 Finland
Acute maxillary sinusitis
0.7
7.9
225
3216
JJA20
NOMESCO Finland
Open biopsy of liver
7.8
7.9
17
22
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.6
7.9
185
1163
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
1.9
7.8
103
539
ZZR00
NOMESCO Finland
Flap of skin
2.1
7.8
85
411
C18
ICD-10 Finland
Malignant neoplasm of colon
9.4
7.8
15
16
JF1CM
NOMESCO Finland
Small bowel extensive MRI with with high intensity magnet
45.1
7.7
9
*
JFG96
NOMESCO Finland
Other operation on intestinal stoma or pouch
45.1
7.7
9
*
WX610
NOMESCO Finland
Patient controlled analgesia
5.0
7.7
23
46
SPAT1109
SPAT
Analgesia with portable analgesic pump
3.9
7.6
29
74
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
3.8
7.6
30
79
JFB50
NOMESCO Finland
Other resection of colon
6.7
7.6
18
27
JWC00
NOMESCO Finland
Reoperation for deep infection in gastroenterological surgery
11.9
7.6
13
11
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
0.7
7.5
435
5556
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
0.5
7.5
74
1346
L17
ICPC
Foot/toe symptom/complaint
0.7
7.5
421
5400
JGA58
NOMESCO Finland
Endoscopic insertion of prosthetic tube into rectum
80.2
7.4
8
*
JFF13
NOMESCO Finland
Terminal enterostomy
6.5
7.4
18
28
D70.82
ICD-10 Finland
Drug-induced neutropenia
2.5
7.4
53
212
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.4
7.4
437
3326
N32.1
ICD-10 Finland
Vesicointestinal fistula
6.0
7.4
19
32
Y83.6
ICD-10 Finland
Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
8.4
7.3
15
18
YX9CD
NOMESCO Finland
Other very extensive CT eamination for dose design of radiotherapy
8.4
7.3
15
18
E83.4
ICD-10 Finland
Disorders of magnesium metabolism
8.4
7.3
15
18
C21
ICD-10 Finland
Malignant neoplasm of anus and anal canal
+∞
7.3
7
*
JFF31
NOMESCO Finland
Other laparoscopic colostomy
+∞
7.3
7
*
JGC20
NOMESCO Finland
Transanal suture
+∞
7.3
7
*
C01DA14
ATC
isosorbide mononitrate; oral
0.7
7.3
345
4538
A02BC03
ATC
lansoprazole; oral
0.8
7.2
551
6801
A07DA03
ATC
loperamide; oral
1.8
7.2
112
623
ZZR30
NOMESCO Finland
Flap of muscle
5.1
7.2
21
41
JFA70
NOMESCO Finland
Suture of small intestine
6.2
7.2
18
29
Z93.4
ICD-10 Finland
Other artificial openings of gastrointestinal tract status
15.8
7.2
11
7
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
3.4
7.2
33
99
XX1CT
NOMESCO Finland
Other puncture with CT guidance
30.1
7.1
9
*
L03
ICPC
Low back symptom/complaint
0.7
7.1
350
4580
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.4
7.1
357
2639
R05FB02
ATC
cough suppressants and expectorants
0.8
7.1
780
9225
K61.0
ICD-10 Finland
Anal abscess
2.8
7.1
43
157
J01AA02
ATC
doxycycline; systemic
0.8
7.0
1979
21341
8140/3-C19.9
ICD-O-3
Adenocarcinoma, NOS, of rectosigmoid junction
4.7
7.0
22
47
M01AE02
ATC
naproxen; oral, rectal
0.8
7.0
1125
12798
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.1
7.0
70
330
T86
ICPC
Hypothyroidism/myxoedema
0.3
7.0
15
483
L15
ICPC
Knee symptom/complaint
0.7
6.9
312
4136
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
0.6
6.9
112
1799
KA3EB
NOMESCO Finland
Antegrade pyelography
4.2
6.9
24
57
JFB63
NOMESCO Finland
Other resection of colon with proximal colostomy and closure of distal stump
13.8
6.9
11
8
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
4.6
6.9
22
48
RD211
NOMESCO Finland
NA
1.8
6.8
118
681
J01FA09
ATC
clarithromycin; systemic
0.8
6.8
480
5985
Z98.8
ICD-10 Finland
Other specified postsurgical states
2.9
6.8
39
135
L01BC04
ATC
carmofur; oral
10.9
6.8
12
11
H02AB04
ATC
methylprednisolone; systemic
0.7
6.8
205
2902
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.6
6.7
172
1107
R03BA05
ATC
fluticasone; inhalant
0.7
6.7
229
3172
JN2AD
NOMESCO Finland
CT examination of lower part of abdomen
7.2
6.7
15
21
WB600
NOMESCO Finland
Neoadjuvant therapy of primary tumour with antibodies
22.5
6.7
9
*
JFA42
NOMESCO Finland
Endoscopic injection in colon
4.2
6.6
23
55
M54.5
ICD-10 Finland
Low back pain
0.8
6.6
532
6522
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.5
6.6
256
1807
ZXC40
NOMESCO Finland
Use of ultrasound
3.9
6.6
25
65
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
2.9
6.6
36
124
E86
ICD-10 Finland
Volume depletion
2.0
6.5
75
375
JFA55
NOMESCO Finland
Other endoscopic procedure using diathermy or heat in colon
4.0
6.5
24
61
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
0.5
6.5
47
933
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
2.5
6.4
46
184
GDB21
NOMESCO Finland
Thoracoscopic segmental resection of lung
5.7
6.4
17
30
JGB97
NOMESCO Finland
Other laparoscopic proctectomy or excision of rectum
69.9
6.4
7
*
JFA76
NOMESCO Finland
Closure of fistula of small intestine
69.9
6.4
7
*
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.8
6.4
542
6611
B01AC04
ATC
clopidogrel; oral
0.7
6.4
325
4236
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
0.7
6.3
152
2243
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
1.8
6.3
102
574
Z93.8
ICD-10 Finland
Other artificial opening status
11.0
6.3
11
10
R01AD12
ATC
fluticasone furoate; nasal
0.8
6.3
376
4792
D95
ICPC
Anal fissure/perianal abscess
4.0
6.3
23
58
L30.9
ICD-10 Finland
Dermatitis, unspecified
0.7
6.3
244
3312
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
3.0
6.3
33
111
JAG46
NOMESCO Finland
Repair of recurrent stomal hernia, laparoscopic
+∞
6.2
6
*
N82.8
ICD-10 Finland
Other female genital tract fistulae
+∞
6.2
6
*
JG003
NOMESCO Finland
Adjuvant radiotherapy of rectum
+∞
6.2
6
*
8249/3-C20.9
ICD-O-3
Neuroendocrine tumor, grade 2 of rectum, NOS
+∞
6.2
6
*
JGW98
NOMESCO Finland
Other transluminal endoscopic operation on rectum
+∞
6.2
6
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
2.2
6.2
59
273
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.4
6.2
289
2117
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
6.3
6.2
15
24
L01
ICPC
Neck symptom/complaint
0.7
6.1
149
2193
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
0.6
6.1
80
1351
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
7.7
6.1
13
17
K63.2
ICD-10 Finland
Fistula of intestine
7.7
6.1
13
17
R42
ICD-10 Finland
Dizziness and giddiness
0.8
6.1
390
4925
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
2.4
6.1
47
197
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
0.7
6.1
152
2223
Y83.4
ICD-10 Finland
Other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
8.6
6.0
12
14
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
2.8
6.0
36
131
N81.6
ICD-10 Finland
Rectocele
0.5
6.0
43
859
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
2671
3301
28.54
307.65
10.0
3.5
ug/l
36.8
21.3
0.71
2459
2703
(3022145) Colonoscopy Study observation
1464
3097
7.28
307.65
1.7
1.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
775
1177
8.12
307.65
6.2
3.1
u/ml
680.3
4499.8
0.91
713
1007
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
969
2928
4.16
283.76
2.4
2.1
g/l
0.2
0.2
1.98
945
2704
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
980
3302
3.70
241.27
2.6
2.7
umol/l
8.1
9.3
0.83
911
2903
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2390
13779
3.19
233.91
5.8
4.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
2358
13549
3.15
230.99
11.3
4.8
g/l
32.9
34.8
46.29
2287
12508
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
393
682
6.35
219.87
5.2
3.1
u/ml
55.5
989.3
1.58
354
626
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
2579
15866
3.21
218.47
15.1
6.1
umol/l
11.1
12.2
4.46
2526
15052
(3044640) Blood type and Crossmatch panel - Blood
1826
9576
2.84
203.02
3.5
2.6
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
806
2718
3.53
194.17
2.1
2.4
u/l
31.1
38.1
1.80
760
2302
(4035726)
794
2656
3.55
193.65
1.4
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1498
7376
2.77
183.64
3.3
2.5
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
2245
13621
2.72
179.37
8.7
10.9
inr
1.2
1.3
13.77
591
3749
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1708
9433
2.54
159.89
2.6
2.6
u/l
57.2
58.9
0.66
1645
8674
(3014576) Chloride [Moles/volume] in Serum or Plasma
998
4291
2.83
154.57
10.2
6.6
mmol/l
105.0
104.4
4.48
987
4173
(3033658) Prothrombin time (PT) actual/Normal
1400
7672
2.35
125.58
5.1
4.1
%
90.1
85.3
10.95
1391
7485
(40768804) Tissue Pathology biopsy report
1834
11540
2.20
114.64
2.9
2.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
1552
9398
2.15
103.97
5.2
4.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
2339
16733
2.14
98.62
17.3
8.7
e9/l
3.9
4.3
14.38
2145
14491
(3037121) Protein [Mass/volume] in Urine
361
1102
3.53
97.92
6.5
2.9
g/l
0.2
0.3
4.21
279
430
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1456
8943
2.05
90.56
4.4
3.2
u/l
31.7
38.0
2.22
1417
8452
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2877
22832
2.30
86.20
16.4
7.7
u/l
89.6
80.2
11.37
2801
21430
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1010
5911
1.99
67.87
9.7
3.0
mmol/l
2.5
2.5
6.37
945
5154
(3003694) ABO and Rh group [Type] in Blood
1156
7185
1.90
64.28
1.4
1.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
502
2306
2.37
62.37
1.6
1.6
—
—
—
0
0
(3002256) Pathology report gross observation
734
3949
2.08
61.58
1.3
1.3
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
888
5185
1.95
58.79
5.7
3.1
mmol/l
0.8
0.8
11.81
854
4811
(3013826) Glucose [Moles/volume] in Serum or Plasma
2314
18161
1.77
55.62
6.0
4.9
mmol/l
7.0
6.9
1.54
2238
17142
(3015377) Calcium [Moles/volume] in Serum or Plasma
1494
10429
1.74
54.18
8.2
3.4
mmol/l
2.3
2.3
1.72
1371
8920
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
321
1274
2.67
54.15
2.6
2.7
u/ml
0.3
0.3
1.39
171
728
(40758558) Short blood count panel - Blood
1114
7336
1.75
48.39
13.7
6.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
1387
9759
1.69
46.95
3.7
3.5
e6/l
106.2
94.4
0.11
1154
7625
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
398
1891
2.24
44.95
9.4
9.5
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
595
3315
1.95
43.84
8.3
7.7
g/l
117.4
120.8
4.44
575
3188
(3030467) Casts [#/volume] in Urine by Automated count
1274
8899
1.67
43.49
3.5
3.4
e6/l
0.5
0.5
0.27
1042
6807
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1861
14322
1.62
42.85
7.2
6.1
mmol/l
1.2
1.2
10.53
1712
12887
(3031040) Bacteria [#/volume] in Urine by Automated count
2384
19522
1.66
42.50
5.0
4.8
e6/l
2699.1
1229.2
0.32
35
332
(36304419) Bacteria [Presence] in Urine
1226
8552
1.66
41.65
3.4
3.3
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
631
3651
1.88
41.26
8.0
7.2
%
97.0
95.3
13.76
606
3506
(3003396) Base excess in Arterial blood by calculation
670
4031
1.81
38.39
7.8
7.0
mmol/l
1.2
1.1
0.29
562
3108
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1986
15778
1.58
38.05
8.3
7.0
mmol/l
1.2
1.2
12.01
1673
13265
(3027801) Oxygen [Partial pressure] in Arterial blood
670
4043
1.81
37.97
7.8
7.0
kpa
14.3
11.9
18.51
642
3845
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
670
4044
1.81
37.94
7.8
7.0
kpa
5.2
5.1
1.40
643
3845
(3025941) Bacteria identified in Stool by Culture
299
1367
2.29
36.80
1.3
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
714
4474
1.74
35.28
2.4
2.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
1468
11013
1.56
35.25
4.2
3.9
e6/l
166.9
113.8
1.16
1195
8109
(3014111) Lactate [Moles/volume] in Serum or Plasma
526
3009
1.88
35.20
6.1
6.7
mmol/l
1.3
1.4
0.73
504
2898
(3000850) Epithelial cells [#/volume] in Urine
999
6865
1.63
34.71
2.8
2.7
e6/l
5.2
4.6
0.50
884
6026
(3026782) Osmolality of Urine
946
6429
1.64
34.30
3.1
2.9
mosm/kgh2o
531.6
557.5
3.71
841
5468
(3048689) Calprotectin [Mass/mass] in Stool
467
2724
1.82
29.02
1.5
2.2
ug/g
276.1
158.9
4.24
373
2128
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
220
992
2.30
27.86
1.3
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
1244
9423
1.49
26.39
3.5
3.3
—
—
—
0
0
(3039000) Anion gap in Blood
179
765
2.41
25.61
8.8
7.1
mmol/l
11.0
11.2
0.31
160
681
(3018572) Chloride [Moles/volume] in Blood
179
765
2.41
25.61
8.8
7.1
mmol/l
106.4
105.3
3.13
160
681
(3047181) Lactate [Moles/volume] in Blood
223
1057
2.18
25.01
7.8
6.2
mmol/l
1.4
1.3
0.40
196
932
(3020779) Urea [Moles/volume] in Serum or Plasma
504
3135
1.71
24.82
5.0
7.0
mmol/l
9.4
10.9
4.40
480
2964
(3014007) Fractional oxyhemoglobin in Arterial blood
379
2178
1.83
24.54
8.7
8.7
%
95.4
93.8
16.44
379
2168
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
748
5180
1.56
23.78
3.4
3.2
e6/l
2.5
1.9
0.80
461
2915
(3008152) Bicarbonate [Moles/volume] in Arterial blood
378
2207
1.80
23.18
8.5
6.7
mmol/l
24.8
24.5
0.71
355
2055
(3000991) Gas panel - Venous blood
455
2840
1.69
21.97
7.2
8.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
2317
20110
1.43
21.92
5.7
4.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
70
194
3.66
21.83
5.2
3.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
147
642
2.34
20.07
1.4
1.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
649
4506
1.54
20.02
2.3
2.7
%
20.3
22.4
3.12
565
3837
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
3046
28047
1.56
19.93
29.4
16.6
mg/l
36.6
26.5
46.48
2828
22799
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
274
1526
1.86
19.52
2.0
1.9
ug/l
2.5
2.6
0.07
247
1332
(3019060) Gas panel - Arterial blood
384
2364
1.70
19.42
6.4
4.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
761
5518
1.48
18.94
3.2
3.0
e6/l
1.1
1.2
0.31
466
3227
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
508
3386
1.58
18.68
4.9
3.6
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
670
4784
1.49
17.89
2.3
2.6
g/l
2.4
2.3
3.83
627
4431
(3022948) Iron [Moles/volume] in Serum or Plasma
711
5140
1.48
17.84
2.3
2.6
umol/l
11.4
12.5
3.46
662
4765
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
258
1464
1.82
17.29
7.0
5.1
%
1.7
1.6
0.32
237
1374
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2425
26618
0.73
16.77
5.9
6.5
mmol/mol
41.1
40.8
0.48
2167
24309
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2521
27501
0.72
16.74
4.1
4.8
mmol/l
4.5
4.5
1.32
2260
25040
(3007930) Methemoglobin/Hemoglobin.total in Blood
253
1443
1.81
16.67
7.1
5.2
%
0.9
0.9
1.32
233
1354
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
743
5539
1.43
15.62
1.8
1.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2503
27242
0.73
15.37
4.1
4.7
mmol/l
1.4
1.4
1.14
2232
24605
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2611
28202
0.73
14.92
4.6
5.4
mmol/l
2.6
2.6
0.75
2315
25533
(3019069) Monocytes/100 leukocytes in Blood
1598
13555
1.32
14.58
4.8
6.2
%
9.0
8.9
0.51
1482
12606
(42870588) Differential panel, method unspecified - Blood
1241
10158
1.34
14.49
4.3
5.7
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
1554
13141
1.32
14.45
4.6
5.9
%
0.6
0.7
11.86
1436
12191
(3006504) Eosinophils/100 leukocytes in Blood
1591
13499
1.32
14.44
4.6
5.9
%
2.7
2.9
2.27
1474
12504
(3051611) Lipemic interference index of Serum or Plasma
84
336
2.54
13.98
4.9
3.6
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
1617
13810
1.31
13.76
4.7
6.1
%
22.5
26.3
29.24
1483
12747
(3024522) Salmonella sp identified in Specimen by Organism specific culture
90
375
2.44
13.74
1.4
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
89
371
2.43
13.58
1.4
1.4
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
298
1882
1.64
13.56
9.0
8.9
mmol/l
24.2
24.3
0.13
284
1749
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
90
378
2.42
13.51
1.4
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
89
373
2.42
13.42
1.4
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
148
763
1.98
13.33
1.2
1.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1014
8136
1.34
13.30
2.2
2.2
mg/l
3.3
3.0
2.77
847
6885
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
88
371
2.41
13.11
1.5
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
148
768
1.97
13.09
1.2
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
146
756
1.97
12.99
1.2
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
88
373
2.39
12.96
1.5
1.4
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
1585
13604
1.29
12.60
4.5
5.8
%
61.3
58.3
14.12
1463
12634
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2436
26403
0.76
12.53
3.7
4.2
mmol/l
1.3
1.3
0.10
2149
23646
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
286
4301
0.64
12.00
1.2
1.2
iu/ml
52.0
37.6
0.53
88
1306
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
269
4085
0.63
11.78
1.2
1.2
u/ml
7.6
14.0
1.11
100
1468
(3018418) pH of Serum or Plasma
1133
9364
1.31
11.76
5.2
4.1
ph
7.4
7.4
0.09
245
1796
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1844
20576
0.79
11.11
3.2
3.8
pmol/l
15.0
15.0
0.47
1604
18351
(3001604) Monocytes [#/volume] in Blood
1641
14343
1.26
10.60
4.4
5.6
e9/l
0.6
0.6
0.77
1401
12225
(3006315) Basophils [#/volume] in Blood
1649
14423
1.26
10.59
4.4
5.6
e9/l
0.0
0.0
11.95
1409
12320
(3026493) Urate [Moles/volume] in Serum or Plasma
665
8377
0.75
10.16
2.5
2.9
umol/l
3642.9
6091.4
0.90
566
7109
(40762365) Oxygen content in Arterial blood by calculation
25
59
4.26
9.83
4.2
2.8
ml/dl
14.1
15.4
1.38
25
54
(3003458) Phosphate [Moles/volume] in Serum or Plasma
565
4322
1.36
9.77
4.6
5.9
mmol/l
1.0
1.0
0.87
528
3989
(3019198) Lymphocytes [#/volume] in Blood
1666
14677
1.25
9.75
4.5
5.7
e9/l
1.6
1.9
2.80
1451
12739
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
290
1977
1.51
9.45
1.5
1.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
51
195
2.64
9.41
1.0
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
160
952
1.71
9.19
1.9
1.7
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
196
1233
1.62
9.10
4.8
3.7
mmol/l
1.3
1.4
0.43
190
1214
(3007853) Bacteria identified in Skin by Aerobe culture
474
3570
1.38
9.00
1.8
1.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2596
27592
0.79
8.95
4.4
5.0
mmol/l
6.1
6.1
1.25
2297
24686
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
606
7608
0.76
8.84
1.6
1.6
mmol/l
1.5
1.4
1.34
493
6284
(3013115) Eosinophils [#/volume] in Blood
1677
14886
1.24
8.83
4.6
5.8
e9/l
0.2
0.2
5.39
1462
12894
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2819
26533
1.29
8.68
30.1
15.9
ml/min/173m2
78.3
74.8
18.01
2581
22090
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1323
11463
1.24
8.66
2.7
2.8
ug/l
175.3
159.8
0.45
1205
10412
(3004716) Salmonella sp identified in Stool by Organism specific culture
169
1042
1.65
8.51
1.2
1.3
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
87
442
1.99
8.30
5.7
6.5
mg/l
12.5
12.1
0.26
74
410
(3037522) Nuclear Ab [Titer] in Serum
233
3394
0.66
8.27
1.2
1.3
titre
528.8
518.3
0.03
41
724
(3018677) aPTT in Platelet poor plasma by Coagulation assay
652
5220
1.30
8.14
1.9
2.0
s
30.3
30.1
0.39
638
5050
(40761511) CBC panel - Blood by Automated count
3013
28707
1.30
7.77
29.7
15.9
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
154
952
1.65
7.71
5.1
3.5
—
—
—
0
0
(3013512) EKG study
1100
9455
1.24
7.49
4.2
4.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1898
17242
1.21
7.43
3.5
3.2
u/l
65.8
55.7
2.97
1780
15788
(3019550) Sodium [Moles/volume] in Serum or Plasma
3090
29608
1.31
7.14
35.1
19.7
mmol/l
139.2
139.6
18.11
3042
28836
(3023103) Potassium [Moles/volume] in Serum or Plasma
3094
29665
1.31
7.02
35.2
19.9
mmol/l
4.0
4.0
23.99
3046
28844
(3021589) Normoblasts [#/volume] in Blood
1420
12593
1.21
6.98
16.1
10.2
e9/l
0.0
0.0
0.51
1182
10257
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
244
1711
1.46
6.95
2.4
2.5
—
—
—
0
0
(3020891) Body temperature
202
1367
1.51
6.87
5.5
4.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
40
162
2.49
6.67
1.3
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
40
162
2.49
6.67
1.3
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
290
2119
1.40
6.59
1.8
1.7
—
—
—
0
0
(3044889) 12 lead EKG panel
2238
20793
1.20
6.45
4.4
4.2
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
39
159
2.47
6.42
1.8
1.6
u/field
2.1
2.6
0.30
30
116
(3012501) Base excess in Blood by calculation
124
766
1.64
6.29
4.4
5.1
mmol/l
2.8
2.7
0.12
88
523
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
71
374
1.92
6.20
3.8
3.6
nmol/l
6.8
21.3
0.48
71
368
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
205
1427
1.46
6.10
2.0
1.9
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
322
2429
1.36
6.04
4.6
4.2
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
414
3250
1.31
5.91
3.0
3.6
kpa
5.8
5.8
0.48
398
3141
(3010421) pH of Blood
139
899
1.57
5.86
4.1
4.8
ph
7.4
7.4
0.52
123
753
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
48
224
2.16
5.84
1.3
1.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
412
3239
1.31
5.81
3.1
3.7
mmol/l
2.0
2.0
0.01
320
2591
(40761539) Cells [Type] in Urine sediment by Light microscopy
24
80
3.01
5.79
1.3
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
48
226
2.14
5.72
1.3
1.4
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
840
9720
0.82
5.64
2.1
2.2
u/l
208.5
222.5
0.19
791
9064
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
479
3861
1.28
5.58
1.6
1.8
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
71
389
1.84
5.54
1.1
1.1
g/l
1.6
1.6
1.13
65
348
(3019225) pH of Specimen
413
3274
1.30
5.48
4.1
4.7
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2399
25308
0.84
5.30
3.8
4.6
mu/l
2.1
2.1
0.39
2093
22674
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
154
1046
1.49
5.22
2.1
3.6
u/ml
32.7
71.7
3.30
148
1009
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
157
1071
1.49
5.21
1.0
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
185
1310
1.43
5.08
2.0
1.8
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
112
715
1.58
5.04
2.1
2.6
umol/l
35.0
35.6
0.07
95
587
(3043410) Blood group antigens tested for on Red Blood Cells
23
83
2.78
4.87
2.8
2.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
118
773
1.54
4.77
3.8
4.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
470
3853
1.25
4.74
1.7
1.8
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
152
1053
1.46
4.71
5.1
3.9
mmol/l
3.8
3.9
3.79
141
970
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
56
990
0.56
4.59
1.2
1.6
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
37
173
2.15
4.55
1.1
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
322
2547
1.29
4.37
4.6
2.8
ml/min/173m2
62.2
61.8
0.05
126
1080
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
601
5105
1.21
4.32
1.1
1.2
u/ml
1.4
1.9
0.44
159
1292
(1002224) Polysomnography panel
47
857
0.54
4.31
1.0
1.1
—
—
—
0
0
(4094501)
44
815
0.53
4.26
1.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
50
892
0.55
4.26
1.1
1.5
—
—
—
0
0
(4010399)
153
2123
0.71
4.22
1.4
1.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
334
2679
1.27
4.07
4.9
4.0
mmol/l
1.2
1.2
1.53
294
2347
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
214
1617
1.34
4.04
2.7
3.8
mmol/l
24.2
24.1
0.06
195
1439
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3063
29702
1.21
3.97
19.3
11.1
u/l
24.2
26.0
7.62
2992
28441
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
110
1599
0.68
3.95
1.2
1.3
au/ml
103.6
58.9
—
5
73
(3020682) Albumin/Creatinine [Ratio] in Urine
936
10454
0.86
3.89
4.2
4.0
mg/mmol
9.1
9.6
0.13
608
6733
(1761868) Lipid panel - Serum or Plasma
754
8558
0.85
3.84
2.9
3.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
51
286
1.79
3.80
1.3
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
706
8049
0.85
3.79
3.0
3.2
ug/l
0.7
0.8
2.75
486
5704
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
127
1777
0.70
3.71
2.4
2.4
au/ml
64.4
24.8
—
6
65
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1018
11268
0.87
3.71
3.9
4.6
%
19.9
22.0
4.48
476
5905
(3002385) Erythrocyte distribution width [Ratio]
2359
22471
1.14
3.59
38.9
20.2
%
14.5
13.9
58.92
2326
21922
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
65
1018
0.63
3.39
1.5
1.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
261
2085
1.27
3.32
3.1
3.6
mmol/l
2.2
1.9
0.66
190
1514
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1342
12372
1.13
3.30
3.6
4.1
ng/l
31.6
91.4
1.11
1064
9458
(3009508) Creatinine [Moles/volume] in Urine
910
10079
0.87
3.27
3.3
3.2
mmol/l
7.6
7.5
0.35
728
8362
(3022217) INR in Platelet poor plasma by Coagulation assay
561
4859
1.18
3.24
19.5
28.2
inr
1.3
1.4
2.38
83
680
(3012516) Albumin [Mass/volume] in Urine
894
9909
0.87
3.24
3.4
3.3
mg/l
386.4
346.1
0.10
606
6413
(3003327) Ova and parasites identified in Stool by Light microscopy
103
718
1.45
3.20
1.8
1.7
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
479
4097
1.19
3.20
2.2
2.4
%
1.7
1.8
0.64
423
3598
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
83
1214
0.68
3.14
1.3
1.3
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
324
2674
1.23
3.12
2.9
3.0
kpa
4.4
4.5
0.45
308
2576
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
45
748
0.60
3.04
1.3
1.7
mg/l
3.0
3.7
0.25
36
542
(3019832) Treponema pallidum Ab [Presence] in Serum
56
882
0.63
3.03
1.2
1.4
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
270
2197
1.25
2.97
3.1
3.7
kpa
5.1
5.2
0.55
249
2009
(3009542) Hematocrit [Volume Fraction] of Blood
2537
24407
1.13
2.95
31.3
18.0
%
37.5
39.0
11.98
1640
15676
(3009343) pH of Capillary blood
266
2164
1.25
2.93
3.1
3.7
ph
7.4
7.4
0.56
39
265
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
211
2635
0.79
2.86
1.5
1.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
83
571
1.46
2.80
3.9
3.6
%
60.0
58.5
0.45
83
571
(3005322) IgE [Units/volume] in Serum or Plasma
104
1427
0.72
2.78
1.2
1.3
u/ml
250.2
232.2
0.08
93
1297
(3008898) HLA-B27 [Presence]
37
628
0.58
2.75
1.1
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
49
776
0.63
2.75
1.4
1.6
iu/ml
1.2
12.3
0.81
14
175
(3030905) Polymorphonuclear cells [#/volume] in Blood
80
551
1.46
2.70
3.4
3.3
e9/l
4.2
4.3
0.12
80
551
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
60
894
0.67
2.56
1.1
1.4
—
—
—
0
0
(3036489) Thrombin time
139
1062
1.32
2.55
2.1
1.9
s
20.8
21.6
1.49
133
959
(3015171) Extractable nuclear Ab [Units/volume] in Serum
62
917
0.67
2.55
1.1
1.2
u/ml
7.4
0.8
—
8
80
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
98
710
1.39
2.53
1.2
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
855
7774
1.13
2.52
4.4
4.2
estimate
0.0
0.0
0.37
299
2502
(3004588) Protein electrophoresis panel - Serum or Plasma
204
2506
0.80
2.43
2.3
2.4
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
66
953
0.69
2.41
2.8
2.3
g/l
0.0
0.0
0.00
61
880
(40767503) Oxygen content in Capillary blood by calculation
102
751
1.37
2.40
2.8
2.5
%
15.3
16.0
0.77
54
388
(3027273) Bicarbonate [Moles/volume] in Venous blood
211
1719
1.24
2.35
3.4
3.4
mmol/l
24.6
25.1
1.10
200
1669
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
98
1314
0.74
2.31
2.3
2.4
g/l
10.1
10.3
0.21
76
1106
(3001893) Eosinophils/100 leukocytes in Pleural fluid
25
133
1.89
2.31
1.4
1.5
%
1.0
2.7
1.28
18
112
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
106
1404
0.75
2.30
2.5
2.4
g/l
3.6
3.8
0.74
70
997
(3045683) HLA typing for celiac disease panel - Blood or Tissue
21
105
2.01
2.30
1.0
1.0
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
98
724
1.36
2.28
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
98
724
1.36
2.28
1.2
1.3
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
21
394
0.53
2.27
3.6
4.5
umol/l
319.7
342.1
0.22
14
337
(3028626) Oxygen [Partial pressure] in Capillary blood
107
802
1.34
2.27
3.1
2.9
kpa
7.9
7.9
0.16
102
734
(3020393) Adenovirus Ag [Presence] in Stool
7
18
3.89
2.25
1.1
1.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
59
0.00
2.24
0.0
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
25
442
0.56
2.22
1.3
1.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
107
1406
0.75
2.21
2.5
2.4
g/l
7.2
7.4
0.57
76
1036
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
69
971
0.70
2.21
2.7
2.3
g/l
0.0
0.0
0.00
62
882
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
107
1405
0.75
2.20
2.5
2.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
35
564
0.62
2.18
1.1
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
197
2398
0.81
2.18
1.9
2.1
nmol/l
10.5
12.4
2.15
163
2061
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
24
129
1.87
2.16
1.5
1.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
24
129
1.87
2.16
1.5
1.7
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
113
863
1.32
2.13
1.3
1.4
ug/g
249.3
271.5
0.58
69
529
(3021901) Oxygen saturation in Capillary blood
93
690
1.36
2.13
3.0
2.9
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
89
1193
0.74
2.12
2.7
2.5
g/l
0.7
1.2
1.51
76
1016
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
36
572
0.63
2.12
1.1
1.3
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
75
1032
0.72
2.12
3.0
2.3
g/l
0.0
0.0
1.50
68
938
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
29
167
1.74
2.11
1.4
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
29
167
1.74
2.11
1.4
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
29
167
1.74
2.11
1.4
1.6
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
24
131
1.84
2.07
1.5
1.7
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
3118
30583
1.15
2.07
45.6
24.5
g/l
127.1
134.5
120.44
3077
30031
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
9
207
0.43
2.06
1.0
1.1
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
38
592
0.64
2.06
1.2
1.4
e6/l
235.0
890.1
1.52
30
482
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
38
592
0.64
2.06
1.1
1.4
e6/l
6.1
25.8
1.16
29
454
(3024731) MCV [Entitic volume]
3117
30575
1.14
2.06
45.1
24.3
fl
91.4
91.7
2.64
3077
30017
(3035941) MCH [Entitic mass]
3117
30575
1.14
2.06
45.1
24.3
pg
30.2
30.5
15.29
3076
30017
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
88
1175
0.74
2.05
1.5
1.8
u/l
36.9
38.3
0.24
77
1001
(3026361) Erythrocytes [#/volume] in Blood
3117
30577
1.14
2.05
45.3
24.4
e12/l
4.3
4.4
75.20
3060
29555
(3000475) Leukocytes [#/volume] in Synovial fluid
54
781
0.69
2.04
1.4
1.6
e6/l
7544.0
15003.3
1.31
40
551
(3010813) Leukocytes [#/volume] in Blood
3117
30581
1.14
2.02
45.3
24.4
e9/l
6.7
6.9
2.70
3061
29551
(3007461) Platelets [#/volume] in Blood
3116
30571
1.14
2.02
45.3
24.4
e9/l
248.8
240.5
8.31
3062
29665
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
21
111
1.90
2.00
1.8
2.5
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
101
769
1.32
1.97
2.7
2.1
g/l
122.3
128.2
1.47
81
558
(3017569) Oxygen content in Arterial blood
31
186
1.67
1.97
2.1
2.3
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
136
1703
0.79
1.97
1.8
1.9
g/l
1.3
1.5
0.26
123
1534
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
251
2952
0.84
1.96
1.3
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
18
335
0.53
1.94
1.3
1.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
703
6419
1.12
1.91
3.5
4.0
ng/l
604.2
540.0
0.09
585
5464
(3007164) IgA [Mass/volume] in Serum or Plasma
518
4650
1.13
1.87
1.4
1.5
g/l
2.6
2.7
0.36
293
2761
(3028707) Methadone [Presence] in Urine by Screen method
5
142
0.35
1.87
1.0
2.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
42
276
1.53
1.86
1.8
1.9
u/field
2.2
1.9
0.13
19
98
(3021440) Promyelocytes/100 leukocytes in Blood
285
2453
1.18
1.85
3.4
4.1
%
0.2
0.1
0.81
106
742
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
28
167
1.68
1.83
1.4
1.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
2207
21315
1.09
1.81
3.3
4.2
mm/h
16.9
13.7
11.95
2005
19552
(3004809) Band form neutrophils/100 leukocytes in Blood
78
580
1.35
1.81
2.9
3.6
%
3.2
1.6
1.47
62
437
(3024263) Appearance of Synovial fluid
8
184
0.43
1.80
1.3
1.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
299
2590
1.17
1.80
3.3
4.0
%
1.1
0.9
0.84
117
800
(3003434) Protein [Mass/volume] in Pleural fluid
74
547
1.36
1.78
1.4
1.5
g/l
30.4
31.7
0.35
62
486
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
28
169
1.66
1.76
2.4
2.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
352
3094
1.15
1.75
2.3
2.5
e9/l
66.4
68.4
0.51
268
2368
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1333
14055
0.92
1.73
2.2
2.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
49
339
1.45
1.72
2.3
2.9
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
83
1084
0.76
1.71
2.4
2.2
g/l
38.0
37.4
0.42
64
926
(3005719) IgG [Mass/volume] in Serum or Plasma
180
2151
0.83
1.71
2.7
2.7
g/l
9.6
10.7
3.21
161
1949
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
27
163
1.66
1.71
1.8
1.9
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
107
1350
0.79
1.69
1.2
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
12
241
0.50
1.67
1.0
1.1
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
10
42
2.38
1.67
1.0
1.2
ng/l
82.6
99.6
—
5
29
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
6
19
3.16
1.66
1.0
1.0
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
103
1301
0.79
1.65
2.5
2.4
g/l
3.0
3.1
0.73
73
1016
(3039443) Prostate specific Ag panel - Serum or Plasma
41
596
0.68
1.65
1.4
1.7
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
117
934
1.26
1.64
3.1
3.2
mmol/l
24.1
25.0
1.10
103
805
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
446
4003
1.13
1.63
3.0
4.0
u/l
263.0
245.0
0.74
425
3771
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
10
211
0.47
1.61
1.9
2.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
12
234
0.51
1.55
1.0
1.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
107
1333
0.80
1.54
1.1
1.2
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
158
1314
1.21
1.54
3.1
4.0
mmol/l
24.9
24.8
0.27
141
1201
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
34
224
1.52
1.54
1.1
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
108
1342
0.80
1.52
1.2
1.2
iu/ml
187.3
140.2
0.47
43
470
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
11
51
2.16
1.50
1.0
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1098
11614
0.92
1.49
2.2
2.2
nmol/l
75.7
78.7
2.59
953
10162
(3042111) Morphology [Interpretation] in Bone marrow Narrative
45
630
0.71
1.49
1.8
1.5
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
62
461
1.35
1.49
1.8
1.9
%
89.2
89.4
0.06
62
456
(3020630) Protein [Mass/volume] in Serum or Plasma
263
3005
0.87
1.49
2.5
2.6
g/l
64.6
66.2
2.51
237
2724
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
34
500
0.68
1.48
1.5
1.3
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
187
1589
1.19
1.46
2.3
2.4
%
0.7
0.6
0.33
177
1517
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
77
593
1.30
1.46
1.0
1.1
u/ml
1.5
8.4
—
7
44
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
11
52
2.12
1.44
1.9
1.7
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
15
266
0.56
1.44
1.1
1.7
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
5
16
3.13
1.44
1.0
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
65
490
1.33
1.43
1.9
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
76
586
1.30
1.43
1.4
1.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1473
14085
1.08
1.42
5.6
5.1
estimate
0.0
0.0
0.00
344
2656
(3045414) Leukocytes [Presence] in Urine
160
1347
1.20
1.40
2.5
1.9
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
30
197
1.53
1.40
3.1
3.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
183
1560
1.18
1.39
3.0
3.8
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
51
372
1.38
1.39
1.3
1.3
u/l
1595.1
337.2
0.46
46
351
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
7
29
2.42
1.39
1.4
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
48
654
0.73
1.37
1.2
1.2
u/ml
2.9
6.2
—
8
105
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
39
550
0.71
1.37
1.7
1.8
iu/l
6.6
4.5
0.29
17
173
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
30
443
0.67
1.35
1.1
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
57
426
1.34
1.35
1.5
1.5
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
8
165
0.48
1.34
1.8
2.0
e9/l
0.1
0.1
—
8
157
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
38
0.00
1.34
0.0
1.9
—
—
—
0
0
(4034850)
73
933
0.78
1.34
13.4
11.0
—
—
—
0
0
(4146454)
51
375
1.37
1.34
3.4
2.6
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
10
47
2.13
1.33
1.5
1.7
ug/l
0.8
3.0
—
5
26
(3025159) Blasts/100 leukocytes in Blood
260
2288
1.15
1.32
3.4
4.1
%
0.6
0.3
0.24
89
614
(3000492) Spirometry study
211
2426
0.86
1.32
1.4
1.5
—
—
—
0
0
(3019977) pH of Arterial blood
31
208
1.49
1.32
1.6
2.5
ph
7.4
7.4
0.14
14
73
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
98
791
1.25
1.31
1.3
1.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
265
2339
1.14
1.30
3.2
3.9
%
0.7
0.6
0.42
83
562
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
53
704
0.75
1.30
1.4
1.8
nmol/l
41.6
43.4
0.28
48
669
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
133
1586
0.83
1.30
1.7
1.9
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
242
2126
1.15
1.27
2.8
3.1
g/l
123.1
128.3
3.23
235
2067
(3052592) Norovirus Ag [Presence] in Stool
12
62
1.94
1.27
1.4
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
94
760
1.24
1.25
1.3
1.6
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
116
0.43
1.25
1.0
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
581
6263
0.91
1.22
4.1
4.3
kg/l
1.0
1.0
0.01
100
968
(3028308) Erythrocytes [#/volume] in Pleural fluid
57
434
1.32
1.21
1.4
1.4
e6/l
19889.3
82589.1
2.32
40
255
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
19
301
0.63
1.21
1.3
1.4
%
41.5
28.2
—
10
181
(3041096) Erythrocytes [Presence] in Urine by Automated
783
7348
1.08
1.21
4.6
3.6
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
55
718
0.76
1.21
1.5
1.9
mg/l
10.6
12.4
0.80
50
657
(3023199) Leukocytes [#/volume] in Pleural fluid
62
480
1.30
1.18
1.5
1.4
e6/l
872.7
1764.3
3.56
45
341
(3011544) Albumin [Mass/volume] in Pleural fluid
8
38
2.11
1.18
1.1
1.1
g/l
20.5
15.6
—
8
31
(3038177) Helicobacter pylori Ab [Presence] in Serum
46
341
1.35
1.17
1.2
1.3
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
57
437
1.31
1.17
1.3
1.5
pmol/l
178.3
270.3
0.38
57
429
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
44
589
0.74
1.16
1.1
1.3
u/l
48.5
40.9
0.12
35
516
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
34
0.00
1.16
0.0
1.0
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
1463
14071
1.07
1.14
4.2
3.8
estimate
0.0
0.0
0.00
337
2629
(3024891) Influenza virus A+B Ag [Presence] in Specimen
82
661
1.25
1.14
1.1
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
27
391
0.69
1.14
2.9
2.0
—
—
—
0
0
(3035880) pH of Pleural fluid
32
224
1.43
1.14
1.3
1.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
32
449
0.71
1.14
2.1
2.6
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
36
0.00
1.14
0.0
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
280
2507
1.13
1.13
1.3
1.5
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
5
112
0.45
1.12
1.4
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
18
282
0.64
1.11
1.0
1.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
1482
14271
1.07
1.11
4.2
3.9
estimate
0.0
0.0
1.08
337
2556
(3000012) Reticulocyte production index
27
184
1.47
1.10
1.3
1.5
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
70
873
0.80
1.09
2.8
2.3
ug/min
181.4
102.7
0.49
39
515
(3033799) Differential panel - Peritoneal fluid
17
104
1.64
1.09
2.4
2.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
7
140
0.50
1.08
1.7
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
64
505
1.27
1.08
1.2
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
20
303
0.66
1.07
1.0
1.7
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
36
261
1.38
1.07
1.0
1.1
u/ml
4.0
2.3
0.47
12
83
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
220
2478
0.88
1.07
3.2
3.9
ng/l
96.4
99.5
0.17
179
2102
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
98
1175
0.83
1.06
3.0
3.4
ratio
1.4
2.7
—
5
87
(3027008) Opiates [Presence] in Urine
20
302
0.66
1.06
1.0
1.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
11
192
0.57
1.05
1.0
2.5
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
26
178
1.46
1.05
1.5
1.6
u/l
12.6
6.3
0.64
16
87
(3049717) Cytology report of Urine Cyto stain
176
1537
1.15
1.05
2.7
2.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
39
288
1.36
1.04
1.3
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
39
288
1.36
1.04
1.3
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
39
288
1.36
1.04
1.3
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
20
301
0.66
1.04
1.0
1.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
627
5870
1.08
1.04
4.2
4.6
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
29
406
0.71
1.04
1.1
1.2
u/ml
218.3
297.1
1.25
22
238
(3021788) Differential panel - Synovial fluid
44
577
0.76
1.03
1.3
1.5
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
5
22
2.27
1.03
1.0
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
28
196
1.43
1.02
1.4
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
28
196
1.43
1.02
1.4
1.6
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
109
0.46
1.00
1.0
1.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
109
0.46
1.00
1.2
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
25
172
1.46
0.99
1.4
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
25
172
1.46
0.99
1.4
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
20
296
0.67
0.98
1.0
1.6
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
0
29
0.00
0.97
0.0
2.2
—
1.2
—
0
20
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
18
272
0.66
0.97
1.2
1.1
u/ml
1.4
1.8
—
8
103
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
28
389
0.72
0.97
1.3
1.5
%
57.4
62.0
0.18
13
244
(3034860) Kappa light chains.free [Mass/volume] in Serum
102
1206
0.84
0.97
2.9
3.4
mg/l
54.7
108.4
0.58
85
975
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
24
165
1.46
0.96
1.4
1.4
%
53.9
68.2
0.74
14
131
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
31
0.00
0.96
0.0
1.1
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
31
0.00
0.96
0.0
1.1
—
80.7
—
0
24
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
31
0.00
0.96
0.0
1.2
—
9.8
—
0
18
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
52
658
0.79
0.95
1.6
1.7
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
22
149
1.48
0.95
1.4
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
12
198
0.60
0.95
1.0
1.1
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
32
0.00
0.95
0.0
1.1
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
32
0.00
0.95
0.0
1.0
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
21
305
0.69
0.94
1.2
1.3
e6/l
123941.3
112204.3
0.04
12
211
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
7
37
1.89
0.94
1.1
1.1
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
15
93
1.62
0.93
1.4
1.5
g/l
11.9
14.3
—
10
71
(3013727) Leukocytes other/100 leukocytes in Blood
18
117
1.54
0.93
2.8
3.7
%
57.3
54.8
0.18
18
112
(3044290) Cell count panel - Cerebral spinal fluid
42
543
0.77
0.92
1.1
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
13
208
0.62
0.91
1.1
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
28
201
1.40
0.91
2.2
2.1
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
18
118
1.53
0.90
1.2
2.5
e6/l
509.7
6695.3
0.52
12
90
(3044007) Cell count panel - Peritoneal fluid
15
94
1.60
0.90
1.1
2.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
58
719
0.80
0.90
3.9
3.6
mg/l
30.4
29.7
0.05
34
455
(40768797) Stomach Pathology biopsy report
381
4120
0.92
0.90
1.3
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
78
937
0.83
0.89
1.1
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
206
1842
1.13
0.89
1.1
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
19
278
0.68
0.89
1.1
1.4
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
88
1044
0.84
0.88
1.7
1.5
titre
228.0
274.9
—
5
47
(3037756) Immunofixation for Serum or Plasma
66
805
0.82
0.88
1.5
1.6
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
103
1205
0.85
0.88
2.9
3.4
mg/l
35.5
66.3
1.73
85
977
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
37
483
0.76
0.88
1.2
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
24
335
0.71
0.88
1.2
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
38
289
1.32
0.87
1.4
1.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
20
287
0.70
0.86
1.1
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
49
614
0.80
0.85
1.1
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
358
3870
0.92
0.85
4.3
4.8
%
32.9
32.9
0.01
225
2529
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
26
187
1.39
0.85
2.2
1.5
u/l
198.2
2389.7
0.77
12
61
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
31
230
1.35
0.84
1.4
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
263
2395
1.11
0.84
1.2
1.5
—
—
—
0
0
(3014891) Appearance of Pleural fluid
10
57
1.76
0.83
2.3
1.5
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
11
65
1.69
0.82
1.1
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
16
237
0.67
0.81
1.1
1.0
u/ml
6.9
4.1
—
9
105
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
10
164
0.61
0.80
1.3
1.7
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
22
305
0.72
0.79
1.0
1.1
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
6
33
1.82
0.79
1.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
16
106
1.51
0.78
1.3
2.2
e6/l
27360.2
21206.9
—
10
65
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
191
1717
1.12
0.78
1.6
1.7
g/l
1.7
1.6
1.25
164
1470
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
15
223
0.67
0.78
1.1
1.2
mmol/l
2.8
2.1
1.02
15
207
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
376
4040
0.92
0.78
11.6
7.7
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
17
246
0.69
0.78
1.2
1.3
—
28.2
—
0
11
(3008401) Mugwort IgE Ab [Units/volume] in Serum
16
234
0.68
0.77
1.1
1.1
u/ml
1.8
1.4
—
8
92
(1617658) Protocol used for examination of sentinel lymph nodes
12
186
0.64
0.76
1.0
1.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
6
34
1.77
0.76
1.3
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
78
919
0.85
0.76
2.6
3.5
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
21
149
1.41
0.75
1.4
1.2
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
5
24
2.08
0.74
10.6
11.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1363
14041
0.95
0.73
4.5
5.4
ug/l
2.5
4.0
2.64
1167
12493
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
8
134
0.60
0.73
1.1
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
18
254
0.71
0.73
1.2
1.5
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
6
108
0.55
0.72
1.2
1.8
ug/l
19.8
92.8
—
6
98
(3006653) Thiamine [Moles/volume] in Blood
10
158
0.63
0.70
1.0
1.2
nmol/l
128.3
137.9
—
10
158
(3009214) Lutropin [Units/volume] in Serum or Plasma
37
465
0.79
0.69
1.3
1.3
u/l
22.8
9.9
2.49
26
375
(3017732) Neutrophils [#/volume] in Blood
205
1871
1.10
0.66
4.5
3.3
e9/l
4.1
4.3
0.23
160
1358
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
247
2678
0.92
0.66
1.5
1.7
%
1.6
1.6
0.21
213
2273
(3001019) Free T4 and TSH panel - Serum or Plasma
66
777
0.85
0.66
1.6
1.7
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
127
1424
0.89
0.65
3.4
3.1
pmol/l
4.3
4.4
0.31
118
1229
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
37
295
1.26
0.65
1.4
1.3
u/l
16.2
13.7
0.13
32
270
(3036481) Cortisol [Moles/volume] in Serum or Plasma
232
2517
0.92
0.64
1.9
2.2
nmol/l
399.4
370.8
1.49
211
2281
(3045788) Cell count panel - Pleural fluid
46
377
1.22
0.64
1.6
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
54
450
1.20
0.64
1.2
1.4
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
5
29
1.72
0.64
1.0
1.0
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
5
29
1.72
0.64
2.8
2.2
u/field
0.6
0.7
—
5
29
(3019420) Tryptase [Mass/volume] in Serum or Plasma
8
129
0.62
0.63
1.0
1.5
ug/l
3.4
9.6
—
8
109
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
66
561
1.18
0.63
1.2
1.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
2218
22540
0.96
0.62
40.7
21.9
g/l
330.0
332.0
21.17
2199
22321
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
17
234
0.73
0.62
1.1
1.0
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
35
435
0.80
0.61
1.4
1.6
mu/l
249.1
277.1
0.40
30
403
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1077
10430
1.05
0.61
2.6
3.2
ng/l
1525.1
1714.1
0.85
944
9063
(3024869) Neuronal Ab [Presence] in Serum
10
63
1.59
0.61
1.0
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
105
0.57
0.61
1.0
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
21
279
0.75
0.61
1.0
1.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
26
335
0.77
0.61
1.3
1.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
43
522
0.82
0.61
1.2
1.4
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3024316) Viscosity of Plasma
0
21
0.00
0.60
0.0
1.4
—
1.9
—
0
12
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
38
308
1.24
0.59
1.8
1.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
84
733
1.15
0.59
1.6
2.6
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
14
97
1.44
0.59
1.4
1.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
16
114
1.41
0.58
1.2
1.6
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
8
53
1.51
0.58
1.6
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
67
777
0.86
0.58
1.4
1.6
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
7
112
0.62
0.58
1.0
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
757
7864
0.95
0.58
1.7
1.6
nmol/l
20.3
20.0
0.19
646
6638
(4281824)
33
264
1.25
0.58
1.2
1.2
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
6
35
1.72
0.57
1.0
1.0
—
9.1
—
0
13
(3017354) Segmented neutrophils/100 leukocytes in Blood
44
364
1.21
0.57
2.5
3.7
%
57.0
57.5
0.04
26
224
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
109
1221
0.89
0.57
2.1
2.6
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
11
73
1.51
0.56
1.4
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
11
160
0.69
0.55
1.2
1.1
u/ml
4.0
2.2
—
5
60
(3047189) Immunofixation for 24 hour Urine
13
183
0.71
0.55
1.7
1.7
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
8
122
0.65
0.54
1.9
2.0
umol/l
54.6
55.8
—
8
91
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
38
1.58
0.54
1.0
1.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
51
432
1.18
0.53
1.4
1.6
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
337
3177
1.07
0.53
2.4
2.9
ng/l
229.6
227.6
0.03
306
2914
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
45
377
1.20
0.53
1.4
1.6
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
21
271
0.77
0.52
1.9
1.6
u/ml
45.2
24.4
—
5
55
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
6
98
0.61
0.52
1.0
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
9
133
0.68
0.51
1.0
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
12
83
1.45
0.51
1.1
1.1
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
24
188
1.28
0.51
1.9
2.1
ug/min
64.8
286.2
—
8
44
(3025130) Human papilloma virus identified in Specimen
19
144
1.32
0.50
1.4
1.8
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
33
401
0.82
0.50
1.1
1.2
miu/ml
249.3
203.6
—
9
148
(3020650) Glucose [Presence] in Urine
10
67
1.49
0.49
1.6
1.4
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
7
107
0.65
0.48
6.0
1.5
%
230.1
180.6
—
7
99
(3016228) CD19 cells/100 cells in Blood
7
108
0.65
0.48
1.9
1.9
%
6.7
8.1
—
7
102
(3008757) Leukocyte morphology finding [Identifier] in Blood
44
372
1.18
0.48
3.5
4.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
15
200
0.75
0.47
2.9
3.8
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
35
290
1.21
0.47
1.1
1.2
u/l
95.4
58.3
0.36
27
197
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
16
211
0.76
0.47
1.2
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
81
720
1.13
0.47
2.8
2.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
35
419
0.83
0.46
1.2
1.4
u/ml
85.6
122.6
—
7
82
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
81
0.62
0.45
1.0
1.1
miu/ml
642.2
1664.6
—
5
81
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
81
0.62
0.45
1.0
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
53
459
1.16
0.45
1.2
1.5
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
24
192
1.25
0.44
6.5
13.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
51
1.37
0.44
1.1
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
7
51
1.37
0.44
1.1
1.4
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
31
1.61
0.43
1.8
1.5
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
12
162
0.74
0.42
1.1
1.0
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
8
57
1.40
0.42
1.1
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
8
57
1.40
0.42
1.1
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
8
57
1.40
0.42
1.1
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
8
57
1.40
0.42
1.1
1.4
—
—
—
0
0
(4015189)
6
95
0.63
0.42
1.5
2.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
44
509
0.86
0.41
1.4
1.3
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
5.3
—
—
—
0
0
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
0
16
0.00
0.41
0.0
1.9
—
1.5
—
0
11
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
24
293
0.82
0.40
2.1
2.2
ml
685.4
629.1
0.47
16
181
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
8
60
1.33
0.40
1.3
1.5
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
12
88
1.36
0.40
5.8
7.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
166
1779
0.93
0.39
1.2
1.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
7
102
0.69
0.39
1.9
2.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
102
931
1.10
0.39
4.7
4.4
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
7
104
0.67
0.39
1.0
2.1
—
30005.7
—
0
16
(3013166) Neutrophils/100 leukocytes in Synovial fluid
7
104
0.67
0.39
1.1
1.3
%
49.7
58.9
—
7
86
(3032868) Hemoglobin electrophoresis panel in Blood
0
19
0.00
0.39
0.0
1.5
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
50
569
0.88
0.38
1.1
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
9
66
1.36
0.38
1.2
1.3
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
5
36
1.39
0.38
1.2
1.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
5
36
1.39
0.38
1.0
1.2
u/l
18.8
21.0
—
5
23
(44813793)
11
147
0.75
0.37
1.0
1.0
—
—
—
0
0
(3048879) Bone marrow aspiration report
8
115
0.69
0.37
1.1
1.6
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
81
1.36
0.36
1.0
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
30
353
0.85
0.36
1.0
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
38
328
1.16
0.36
1.8
1.6
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
53
597
0.89
0.36
1.1
1.6
nmol/l
1.0
0.8
1.18
41
489
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
76
0.66
0.35
1.0
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
32
374
0.85
0.35
3.0
3.6
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
5
80
0.62
0.35
1.4
1.4
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
80
0.62
0.35
1.0
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
59
527
1.12
0.35
3.2
3.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
32
273
1.17
0.35
1.2
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
17
211
0.80
0.34
1.4
1.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
30
351
0.85
0.34
1.0
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
25
209
1.20
0.34
1.4
1.2
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
37
425
0.87
0.33
1.1
1.1
iu/ml
174.1
71.3
—
10
80
(4027681)
10
133
0.75
0.33
1.3
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
41
467
0.88
0.33
1.1
1.1
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
6
89
0.67
0.33
1.0
1.2
—
24.9
—
0
12
(3035320) C reactive protein [Mass/volume] in Body fluid
25
210
1.19
0.32
2.7
2.5
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
10
74
1.35
0.32
3.0
2.3
mmol/l
9.4
8.0
—
5
43
(3044927) Protein electrophoresis panel - Urine
34
391
0.87
0.32
1.1
1.2
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
23
192
1.20
0.32
1.3
1.2
mmol/l
10.2
11.9
—
8
66
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
22
183
1.20
0.31
1.5
1.3
u/l
50.9
31.2
0.98
16
141
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
13
101
1.29
0.31
1.3
1.3
%
17.9
23.2
—
7
79
(1175426) CD3 cells/100 lymphocytes in Blood
15
186
0.81
0.31
1.4
2.0
%
71.7
71.3
0.03
15
172
(3028433) Virus identified in Specimen by Culture
7
98
0.71
0.30
1.4
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
54
1.30
0.30
1.3
1.5
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
10
75
1.33
0.30
5.5
7.7
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
14
111
1.26
0.30
1.4
2.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
14
111
1.26
0.30
1.4
2.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
212
2018
1.05
0.30
3.4
3.2
—
—
—
0
0
(4062490)
21
249
0.84
0.29
1.4
1.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
8
110
0.73
0.28
1.1
1.1
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
21
177
1.19
0.27
3.1
2.1
—
29.2
—
0
13
(3000093) Morphology [Interpretation] in Blood Narrative
36
318
1.13
0.27
1.1
1.1
—
—
—
0
0
(4133840)
8
66
1.21
0.26
1.1
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
60
656
0.91
0.26
1.3
1.6
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
66
718
0.92
0.26
1.4
1.4
g/l
0.2
0.2
0.03
60
679
(3045716) Anion gap in Serum or Plasma
21
178
1.18
0.26
2.2
2.3
mmol/l
8.9
9.2
0.21
15
137
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
72
0.69
0.26
1.2
1.4
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
5
74
0.68
0.26
1.4
1.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
94
877
1.07
0.26
1.8
1.5
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
75
0.67
0.25
1.2
1.3
ug/l
10.6
9.3
—
5
75
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
678
6929
0.97
0.25
1.7
1.7
pmol/l
15412669.8
25337303.2
0.26
558
5640
(3036603) Volume of Urine
24
207
1.16
0.25
1.8
1.5
ml
1733.6
1832.1
—
8
55
(3004616) Nuclear Ab [Presence] in Serum
30
340
0.88
0.25
1.1
1.2
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
13
105
1.24
0.24
1.9
1.2
umol/l
18.0
14.7
—
7
58
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
15
180
0.83
0.24
1.4
2.0
%
17.9
15.3
—
8
72
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
10
78
1.28
0.24
1.2
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
358
3471
1.03
0.24
1.7
1.4
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
35
312
1.12
0.24
1.6
2.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1094
10775
1.02
0.23
4.6
4.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
40
443
0.90
0.23
1.2
1.3
iu/l
44.5
33.0
1.14
33
375
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
12
147
0.82
0.23
1.0
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
22
253
0.87
0.22
1.2
1.6
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
7
91
0.77
0.22
1.4
1.2
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
5
40
1.25
0.22
15.0
11.6
mmol/l
5.6
5.7
—
5
40
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
25
219
1.14
0.22
1.0
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
29
257
1.13
0.22
1.0
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
240
2487
0.96
0.22
1.4
1.4
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
5
42
1.19
0.21
2.4
2.2
—
—
—
0
0
(3007542) Rye IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
0.1
—
0
5
(3017937) Magnesium [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013762) Body weight Measured
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
2.5
—
0
11
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
3.9
—
0
11
(3024980) IgG subclass 4 [Mass/volume] in Serum
35
388
0.90
0.21
1.4
1.6
g/l
0.8
0.9
0.29
28
294
(3006969) Lambda light chains [Mass/volume] in Urine
0
12
0.00
0.21
0.0
1.1
—
0.0
—
0
6
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1314
13295
0.98
0.21
2.1
2.1
pmol/l
86.0
93.0
6.35
754
6985
(3028679) Herpes simplex virus Ab [Presence] in Serum
8
102
0.78
0.21
1.1
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
51
469
1.09
0.21
1.3
1.6
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
5
43
1.16
0.21
2.4
2.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
30
335
0.89
0.21
1.2
1.3
nmol/l
—
—
—
0
0
(37019676) Renin [Units/volume] in Plasma --supine
0
13
0.00
0.21
0.0
1.0
—
11.5
—
0
8
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
42
460
0.91
0.21
1.2
1.2
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
15
176
0.85
0.20
1.4
2.0
—
—
—
0
0
(44790048)
31
344
0.90
0.19
1.1
1.5
—
—
—
0
0
(44806118)
31
344
0.90
0.19
1.1
1.5
—
—
—
0
0
(44790049)
31
344
0.90
0.19
1.1
1.5
—
—
—
0
0
(44790047)
31
344
0.90
0.19
1.1
1.5
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
70
747
0.94
0.19
1.4
1.4
g/l
1.1
1.2
0.52
64
705
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
15
175
0.86
0.18
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
15
175
0.86
0.18
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
15
175
0.86
0.18
1.1
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
16
137
1.17
0.18
1.0
1.7
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
18
156
1.15
0.18
1.0
1.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
7
62
1.13
0.17
5.1
7.9
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
67
0.75
0.17
1.2
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
8
68
1.18
0.16
1.0
1.0
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
22
246
0.89
0.16
1.4
1.3
g/l
0.3
0.4
0.56
17
172
(3028192) IgG subclass 2 [Mass/volume] in Serum
22
246
0.89
0.16
1.4
1.3
g/l
2.2
3.0
1.85
17
172
(3027135) IgG subclass 1 [Mass/volume] in Serum
22
246
0.89
0.16
1.4
1.3
g/l
5.9
7.1
0.80
17
172
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
31
339
0.91
0.16
1.1
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
81
769
1.05
0.16
1.3
1.5
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
15
172
0.87
0.15
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
15
172
0.87
0.15
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
15
172
0.87
0.15
1.1
1.1
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
6
78
0.77
0.15
6.2
1.5
%
218.0
210.3
—
6
72
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
10
83
1.21
0.15
1.3
1.2
—
—
—
0
0
(44806420)
10
119
0.84
0.15
2.6
2.5
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
20
224
0.89
0.15
1.7
2.1
ug/l
1.6
2.0
0.82
14
187
(3001964) Herpes simplex virus Ag [Presence] in Specimen
9
78
1.15
0.15
1.2
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
295
2880
1.03
0.15
1.3
1.5
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
27
296
0.91
0.14
1.1
1.2
mmol/l
7.5
7.6
0.04
22
218
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
629
6198
1.02
0.14
1.6
1.7
mg/l
2.3
1.4
2.83
512
4845
(3022689) Creatine [Moles/volume] in Urine
7
87
0.80
0.14
1.3
1.5
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
88
0.79
0.14
1.9
1.9
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
11
93
1.18
0.14
1.0
1.2
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
29
316
0.92
0.14
1.3
1.3
mosm/kgh2o
274.3
276.6
0.25
23
227
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
12
139
0.86
0.14
1.1
1.2
mmol/l
5.9
6.2
0.31
12
133
(3004451) EKG impression Narrative
20
179
1.12
0.14
1.3
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
17
191
0.89
0.13
2.6
1.9
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
42
395
1.06
0.12
2.6
3.8
u/ml
17.4
34.4
2.38
42
383
(3027923) C peptide [Moles/volume] in Serum or Plasma
17
153
1.11
0.11
1.3
1.3
nmol/l
1.1
1.1
0.08
12
116
(3035933) Granulocytes/100 leukocytes in Blood
5
47
1.06
0.09
1.4
1.3
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
33
350
0.94
0.09
1.3
1.3
pmol/l
227.3
270.3
0.56
21
266
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
12
134
0.90
0.08
9.7
6.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
6
58
1.03
0.08
1.0
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
13
144
0.90
0.08
5.2
3.9
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
144
0.90
0.08
1.1
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
25
267
0.94
0.08
1.0
1.5
—
—
—
0
0
(4024509)
33
312
1.06
0.08
1.7
1.5
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
5
62
0.81
0.08
1.4
1.4
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
16
146
1.10
0.08
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
16
146
1.10
0.08
1.0
1.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
88
906
0.97
0.08
1.6
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
169
1723
0.98
0.08
6.0
3.6
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
6
71
0.84
0.07
1.2
1.4
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
6
73
0.82
0.07
1.0
1.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
16
174
0.92
0.07
1.3
1.3
u/ml
0.2
1.7
—
9
90
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
6
74
0.81
0.07
1.0
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
8
76
1.05
0.07
2.4
2.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
12
108
1.11
0.07
1.2
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
7
81
0.86
0.07
1.1
1.3
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
36
377
0.95
0.07
1.4
1.4
mu/l
43.1
71.1
1.18
30
335
(3016650) Hepatitis A virus Ab [Presence] in Serum
37
387
0.96
0.07
1.0
1.0
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
8
93
0.86
0.06
1.0
1.7
mmol/l
-1.3
1.0
—
8
88
(40768446) Kidney Pathology biopsy report
9
102
0.88
0.06
1.4
1.6
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
9
103
0.87
0.06
1.4
2.0
ug/l
87.7
49.2
—
9
98
(3016750) Collection duration of Urine
19
203
0.94
0.06
2.2
2.0
min
487.7
493.3
0.08
14
145
(3019309) Folate [Moles/volume] in Red Blood Cells
664
6595
1.01
0.06
1.7
1.8
nmol/l
1143.9
1165.3
0.22
503
4921
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
15
162
0.93
0.06
1.3
1.5
nmol/l
0.6
0.2
—
9
119
(3011397) Hemoglobin [Presence] in Urine by Test strip
680
6843
0.99
0.06
3.4
3.8
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
78
799
0.98
0.05
2.9
3.1
nmol/l
0.8
0.8
0.07
59
603
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
23
218
1.06
0.05
1.1
1.1
—
3.9
—
0
11
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
12
110
1.09
0.05
1.6
1.6
umol/l
103.8
105.1
—
5
67
(3038026) Centromere Ab [Units/volume] in Serum
23
242
0.95
0.05
1.1
1.1
—
54.2
—
0
10
(4268621)
25
238
1.05
0.05
2.4
2.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
14
130
1.08
0.04
1.3
1.1
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
80
784
1.02
0.04
2.4
2.9
mg/l
1.8
1.7
0.58
74
698
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
47
483
0.97
0.04
1.2
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
25
261
0.96
0.04
1.1
1.8
%
10.7
10.9
0.09
25
261
(3002523) Influenza virus A Ag [Presence] in Specimen
27
259
1.04
0.04
1.0
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
37
382
0.97
0.04
1.7
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
269
2710
0.99
0.03
3.0
3.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
49
502
0.98
0.03
1.9
2.8
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
39
401
0.97
0.03
1.1
1.2
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
27
280
0.96
0.03
1.3
1.2
nmol/l
331.8
331.6
0.00
20
230
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
18
189
0.95
0.03
1.2
1.4
umol/l
15.8
14.4
0.26
18
176
(3000034) Microalbumin [Mass/volume] in Urine
32
311
1.03
0.02
3.4
3.2
mg/l
34.0
30.8
0.08
23
247
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
44
432
1.02
0.01
1.3
1.5
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
44
432
1.02
0.01
1.5
2.2
mg/l
52.6
25.0
—
10
94
(3003181) Sodium [Moles/volume] in Urine
59
598
0.99
0.01
1.6
1.3
mmol/l
67.4
62.4
0.34
40
474
(4306422)
34
333
1.02
0.01
1.2
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
39
397
0.98
0.01
1.2
1.3
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
10
106
0.94
0.01
1.2
1.3
—
0.3
—
0
9
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
12
126
0.95
0.00
1.2
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
13
124
1.05
0.00
1.2
1.3
—
—
—
0
0
(4211845)
15
156
0.96
0.00
4.9
3.7
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
35
356
0.98
0.00
1.3
1.2
u/ml
5.3
3.2
0.31
15
112
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
322
3226
1.00
0.00
1.9
2.4
ug/l
5.7
7.3
1.26
277
2790
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
23
230
1.00
0.00
1.1
1.1
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
14
138
1.01
0.00
1.9
1.9
%
92.7
97.9
0.22
14
131
(3020491) Glucose [Moles/volume] in Blood
22
221
1.00
0.00
1.4
2.0
mmol/l
7.1
6.8
0.19
15
144
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
145
1.03
0.00
1.1
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
47
467
1.01
0.00
3.6
2.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
42
415
1.01
0.00
1.0
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
49
489
1.00
0.00
1.4
1.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
18
176
1.02
0.00
3.9
3.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
152
1524
1.00
0.00
1.2
1.4
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
30
301
1.00
0.00
2.1
2.0
—
1.3
—
0
12
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
26
264
0.98
0.00
1.1
1.1
u/ml
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
13
127
1.02
0.00
1.6
2.4
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
35
346
1.01
0.00
1.3
1.2
u/ml
3.3
5.0
0.70
19
155
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
34
345
0.99
0.00
1.2
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
12
115
1.04
0.00
1.2
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
8
89
0.90
0.00
1.3
1.5
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
6
65
0.92
0.00
1.8
1.5
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
8
80
1.00
0.00
1.0
2.0
%
35.3
29.0
—
8
72
(3016244) Insulin [Units/volume] in Serum or Plasma
9
94
0.96
0.00
1.6
2.7
mu/l
18.3
19.6
—
9
89
(3041672) Baker's yeast Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
1.3
—
0
5
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762887) Creatinine [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
50
1.00
0.00
1.0
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
78
0.90
0.00
1.0
1.1
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
5
49
1.02
0.00
1.0
1.4
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015350) Toxocara sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
6
62
0.97
0.00
1.0
1.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
7
77
0.91
0.00
2.0
2.4
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002568) Complement factor B [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
0.2
—
0
8
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
9
0.00
0.00
0.0
5.8
—
50.6
—
0
9
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
8
81
0.99
0.00
1.0
2.0
%
13.8
9.4
—
8
69
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
440.4
—
0
7
(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022229) Phosphate [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
19.8
—
0
6
(3006567) Chloride [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015147) Influenza virus A IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
1.5
—
0
6
(3001186) Copper [Moles/volume] in Serum or Plasma
5
55
0.91
0.00
1.2
1.1
umol/l
19.4
16.6
—
5
48
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
1478.7
—
0
6
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_RECTUM – Malignant neoplasm of rectum
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).